Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Thoracic Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 599 articles:
HTML format



Single Articles


    April 2024
  1. BUCHANAN CE, Iskander M, Anwaruddin S, Mason PJ, et al
    Novel valve-in-surgical bioprosthetic transcatheter aortic valve replacement: Undermining iatrogenic coronary obstruction with radiofrequency needle (UNICORN).
    Catheter Cardiovasc Interv. 2024 Apr 8. doi: 10.1002/ccd.31038.
    PubMed     Abstract available


  2. KORNOWSKI R
    Extent of cardiac damage before transcatheter aortic valve replacement: Beyond aortic stenosis per se.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31031.
    PubMed    


  3. BAEKKE PS, Gran LL, Jorgensen TH, Ghattas A, et al
    Extent of cardiac damage and hospitalization burden in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31015.
    PubMed     Abstract available


  4. AL-OGAILI A, Alexandrou M, Rempakos A, Mutlu D, et al
    Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31019.
    PubMed     Abstract available


    March 2024
  5. BIANCARI F, Makikallio T
    Hospital racial composition and outcomes after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Mar 29. doi: 10.1002/ccd.31022.
    PubMed    


  6. BASMAN C, Landers D, Kliger C, Rodriguez-Barragan K, et al
    Balloon rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2024 Mar 28. doi: 10.1002/ccd.31029.
    PubMed     Abstract available


  7. GIORDANO A, Biondi-Zoccai G
    Which is the best approach for percutaneous coronary intervention of chronic total occlusions? The one you feel most confident with!
    Catheter Cardiovasc Interv. 2024 Mar 20. doi: 10.1002/ccd.31011.
    PubMed    


  8. SETO AH, Yau P
    Does ejection fraction matter in choosing between percutaneous coronary intervention and coronary artery bypass surgery?
    Catheter Cardiovasc Interv. 2024 Mar 17. doi: 10.1002/ccd.31014.
    PubMed    


  9. POOMMIPANIT P, Tashtish N
    The utility of guide catheter extensions (GCE) in coronary interventions and specifically chronic total occlusion (CTO) interventions.
    Catheter Cardiovasc Interv. 2024 Mar 15. doi: 10.1002/ccd.31012.
    PubMed    


  10. EL SHERBINI AH, Servito M, Zidan A, Elsherif S, et al
    Sex differences in the outcomes after transcatheter aortic valve replacement with newer generation devices: A meta-analysis.
    Catheter Cardiovasc Interv. 2024 Mar 10. doi: 10.1002/ccd.30985.
    PubMed     Abstract available


  11. VELAGALETI RS, Harrell C, Michalski J, Lefevre T, et al
    Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Mar 5. doi: 10.1002/ccd.30995.
    PubMed     Abstract available


  12. FILHO EM, Araujo GN, Machado GP, Padilla L, et al
    Guide catheter extension use are associated with higher procedural success in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2024 Mar 3. doi: 10.1002/ccd.30987.
    PubMed     Abstract available


  13. DENBY K, Zaczkiewicz M, Banthiya S, Mashayekhi K, et al
    Understanding large vessel perforation requiring treatment with covered stent implantation: A case series.
    Catheter Cardiovasc Interv. 2024;103:570-579.
    PubMed     Abstract available


  14. KIEKENAP J, Sun X, Hao Y, Steitz M, et al
    Long-term function of a novel autologous transcatheter pulmonary heart valve implant in an adult animal model.
    Catheter Cardiovasc Interv. 2024;103:597-606.
    PubMed     Abstract available


  15. PAN W, Zhou D, Hijazi ZM, Qureshi SA, et al
    2024 Statement from Asia expert operators on transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2024;103:660-669.
    PubMed     Abstract available


  16. ALDOSS O, Porayette P, Mohammad Nijres B
    Bilateral Harmony valve placement in branch pulmonary arteries.
    Catheter Cardiovasc Interv. 2024;103:612-617.
    PubMed     Abstract available


  17. UZUN F, Guner A, Demirci G, Ciloglu K, et al
    Comparison of long-term outcomes of double kissing crush versus T and minimal protrusion techniques in complex bifurcation lesions: The EVOLUTE-CRUSH II registry.
    Catheter Cardiovasc Interv. 2024;103:511-522.
    PubMed     Abstract available


  18. SCHELLER B
    Drug-coated balloons for complex coronary de novo lesions.
    Catheter Cardiovasc Interv. 2024;103:688-689.
    PubMed    


  19. CHAUS A, Uretsky BF
    Treating cardiac tamponade due to malignant effusion with percutaneous balloon pericardiotomy: Back to the future.
    Catheter Cardiovasc Interv. 2024;103:682-683.
    PubMed    


  20. ALEKSANDRIC S, Beleslin B
    Editorial comment: SYNTAX score II 2020 as a tool for decision making on revascularization strategy in high-risk patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2024;103:680-681.
    PubMed    


  21. PARK WY, Kim GB, Lee SY, Kim AY, et al
    The adaptability of the Pulsta valve to the diverse main pulmonary artery shape of native right ventricular outflow tract disease.
    Catheter Cardiovasc Interv. 2024;103:587-596.
    PubMed     Abstract available


    February 2024
  22. PENG S, Rempakos A, Mastrodemos OC, Rangan BV, et al
    Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.30994.
    PubMed     Abstract available


  23. ANDREKA J, Sasi V, Toth GG, Ruzsa Z, et al
    Stent graft implantation from distal radial access-A novel way to treat femoral access site complication during transcatheter aortic valve replacement: A case report.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31001.
    PubMed     Abstract available


  24. BOUSSOFARA A, Godin M, Canville A, Baala B, et al
    Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30969.
    PubMed     Abstract available


  25. MAIANI S, Nardi G, Di Mario C, Meucci F, et al
    Patient-specific computer simulation of transcatheter aortic valve replacement in patients with previous mechanical mitral prosthesis: A case series.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30984.
    PubMed     Abstract available


  26. HASHEM A, Goldsweig AM
    Funny things are everywhere: Combatting geographic disparities in aortic stenosis care.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30971.
    PubMed    


  27. CORCIONE N, Biondi-Zoccai G
    ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease.
    Catheter Cardiovasc Interv. 2024 Feb 22. doi: 10.1002/ccd.30982.
    PubMed    


  28. CHEN Y, Xiao Y, Huang R, Jiang F, et al
    Association between hospital racial composition and aortic valve replacement outcomes: A national inpatients sample database analysis.
    Catheter Cardiovasc Interv. 2024 Feb 14. doi: 10.1002/ccd.30970.
    PubMed     Abstract available


  29. WANG Y, Zhai M, Mao Y, Yang T, et al
    Transcatheter tricuspid valve replacement for functional tricuspid regurgitation after left-sided valve surgery: A single-center experience.
    Catheter Cardiovasc Interv. 2024 Feb 14. doi: 10.1002/ccd.30972.
    PubMed     Abstract available


  30. KELLEY BP, Glasco S, Sang CJ 3rd, Yoo B, et al
    To flip or not: Case series of coronary angioplasty in patients with right-sided heart.
    Catheter Cardiovasc Interv. 2024 Feb 12. doi: 10.1002/ccd.30973.
    PubMed     Abstract available


  31. VAN BAKEL PAJ, Ahmed Y, Hou H, Sukul D, et al
    Geographic variation in aortic stenosis treatment and outcomes among Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2024 Feb 8. doi: 10.1002/ccd.30959.
    PubMed     Abstract available


  32. SPIRITO A, Cohen R, Sartori S, Vogel B, et al
    Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 5. doi: 10.1002/ccd.30960.
    PubMed     Abstract available


  33. JOLLEY MA, Sulentic A, Amin S, Gupta M, et al
    Introduction of transcatheter edge-to-edge repair in patients with congenital heart disease at a children's hospital.
    Catheter Cardiovasc Interv. 2024;103:326-334.
    PubMed     Abstract available


  34. SUZUKA Y, Hirano K, Tokuda T, Diaz JP, et al
    JETWING technique: Combination therapy of JETSTREAM(?) and aggressive wire recanalization in calcified atheroma and dilatation technique for eccentric heavy calcified plaques using WINGMAN for insertion of protection wire.
    Catheter Cardiovasc Interv. 2024;103:335-339.
    PubMed     Abstract available


  35. RIVERO-SANTANA B, Jimenez-Valero S, Jurado-Roman A, Galeote G, et al
    The BALTO Registry: Long-term results of percutaneous BALloon pericardioTomy in oncological patients.
    Catheter Cardiovasc Interv. 2024;103:482-489.
    PubMed     Abstract available


  36. BOSCAMP NS, Maschietto N, Porras D
    Transcatheter pulmonary valve replacement in surgically-created double-barrel right ventricular outflow tracts: A single center case-series.
    Catheter Cardiovasc Interv. 2024;103:455-463.
    PubMed     Abstract available


    January 2024
  37. VOLET C, Puricel S, Cook ST, di Cicco P, et al
    Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30961.
    PubMed     Abstract available


  38. CHICHAREON P, Chamnarnphol N, Chandavimol M, Suwannasom P, et al
    Updated CRUSADE score to predict in-hospital bleeding: External validation in the Thai percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2024 Jan 14. doi: 10.1002/ccd.30940.
    PubMed     Abstract available


  39. JONES D, Spirito A, Sartori S, Vogel B, et al
    Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Jan 3. doi: 10.1002/ccd.30939.
    PubMed     Abstract available


  40. KAWAMURA A, Egami Y, Okamoto N, Kawanami S, et al
    Difference between antegrade and retrograde orbital atherectomy system debulking using an artificial pulsatile heart model.
    Catheter Cardiovasc Interv. 2024;103:42-50.
    PubMed     Abstract available


  41. SHEKILADZE N, Sandesara PB, Tai Z, Maisuradze N, et al
    Technical aspects of entrapped coronary guidewire retrieval using rotational atherectomy device: A case series.
    Catheter Cardiovasc Interv. 2024;103:89-96.
    PubMed     Abstract available


  42. GUPTA A, Shrivastava A, Chhikara S, Mamas MA, et al
    Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study).
    Catheter Cardiovasc Interv. 2024;103:51-60.
    PubMed     Abstract available


  43. HEATON J, Imburgio S, Dandu S, Johal A, et al
    Geographic variability and operator trends of transcatheter edge-to-edge repair in the United States.
    Catheter Cardiovasc Interv. 2024;103:147-152.
    PubMed     Abstract available


  44. JIN P, Wang Y, Liu Y, Yang J, et al
    Transapical concomitant transseptal transcatheter closure of a giant mitral paravalvular leak under three-dimensional printing guidance.
    Catheter Cardiovasc Interv. 2024;103:243-247.
    PubMed     Abstract available


    December 2023
  45. SAITO T, Kuno T, Ueyama HA, Kampaktsis PN, et al
    Transcatheter edge-to-edge mitral valve repair for mitral regurgitation in patients with cardiogenic shock: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Dec 29. doi: 10.1002/ccd.30944.
    PubMed     Abstract available


  46. DEMIRCI G, Aslan S, Guner A, Demir AR, et al
    Clinical implication of the Naples prognostic score on transcatheter aortic valve replacement in patients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30929.
    PubMed     Abstract available


  47. HANSON I, Goldstein JA
    Percutaneous coronary intervention: Before, after, or during TAVR?
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30941.
    PubMed    


  48. FISCHER J, Steffen J, Arlart T, Haum M, et al
    Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30927.
    PubMed     Abstract available


  49. AROW Z, Konigstein M, Vaknin-Assa H, Witberg G, et al
    Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Dec 14. doi: 10.1002/ccd.30924.
    PubMed     Abstract available


  50. NOORI M, Christiansen EH, Raungaard B, Junker A, et al
    Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Dec 13. doi: 10.1002/ccd.30937.
    PubMed     Abstract available


  51. YANG Y, Chen J, Dong L, Lu Y, et al
    Transcatheter mitral valve replacement with Mi-thos system: First-in-human experience.
    Catheter Cardiovasc Interv. 2023 Dec 9. doi: 10.1002/ccd.30926.
    PubMed     Abstract available


  52. BARBASH IM, Wasserstrum Y, Erlebach M, Guetta V, et al
    Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 7. doi: 10.1002/ccd.30921.
    PubMed     Abstract available


  53. JIN Q, Long Y, Zhang G, Pan X, et al
    Five-year follow-up after percutaneous pulmonary valve implantation using the Venus P-valve system for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract.
    Catheter Cardiovasc Interv. 2023 Dec 6. doi: 10.1002/ccd.30916.
    PubMed     Abstract available


  54. PIEDIMONTE G, Azzalini L, Ferrarotto L, Mangione R, et al
    Applicability of J-CTO channel score to predict microcatheter tracking during retrograde percutaneous coronary intervention of chronic total occlusions: Insights from the SURFING MICRO registry.
    Catheter Cardiovasc Interv. 2023 Dec 4. doi: 10.1002/ccd.30928.
    PubMed     Abstract available


  55. BASAVARAJAIAH S, Kalkat H, Bhatia G, Cortese B, et al
    How to perform a successful drug-coated balloon angioplasty? Tips and tricks.
    Catheter Cardiovasc Interv. 2023;102:1238-1257.
    PubMed     Abstract available


  56. MOVAHED MR
    Movahed coronary bifurcation classification should be the preferred classification for studying true bifurcation lesions as it summarizes true bifurcation lesions in only one simple category called B2 Lesion with limitless optional suffixes.
    Catheter Cardiovasc Interv. 2023;102:1263-1264.
    PubMed    


  57. ORZALKIEWICZ M, Bruno AG, Saia F, Palmerini T, et al
    A novel high-risk aortic root anatomy for right coronary artery occlusion during TAVI.
    Catheter Cardiovasc Interv. 2023;102:1389-1392.
    PubMed     Abstract available


  58. PELLEGRINI C, Freissmuth M, Rheude T, Graas D, et al
    Implantation depth of balloon-expandable transcatheter heart valves and risks for permanent pacemaker implantation and midterm adverse events.
    Catheter Cardiovasc Interv. 2023;102:1301-1310.
    PubMed     Abstract available


  59. CURIO J, Khokhar AA, Beneduce A, Mylotte D, et al
    Patient-specific commissural alignment for ACURATE neo2 implantation in degenerated surgical bioprostheses.
    Catheter Cardiovasc Interv. 2023;102:1401-1405.
    PubMed     Abstract available


    November 2023
  60. SCHNEEBERGER Y, Sarwari H, Koll B, Demal TJ, et al
    Balloon-expandable transcatheter heart valves for treatment of aortic valve stenosis in patients with large aortic annuli: Evaluation of deployment balloon overfilling strategies.
    Catheter Cardiovasc Interv. 2023 Nov 30. doi: 10.1002/ccd.30922.
    PubMed     Abstract available


  61. ALJABBARY TF, Komatsu I, Ochiai T, Fremes SE, et al
    Cusp overlap method for self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Nov 27. doi: 10.1002/ccd.30910.
    PubMed     Abstract available


  62. JAVAID AI, Michalek JE, Gruslova AB, Hoskins SA, et al
    Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Nov 23. doi: 10.1002/ccd.30913.
    PubMed     Abstract available


  63. ANDROSHCHUK V, Chehab O, Prendergast B, Rajani R, et al
    Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review.
    Catheter Cardiovasc Interv. 2023 Nov 22. doi: 10.1002/ccd.30918.
    PubMed     Abstract available


  64. SIMSEK B, Rempakos A, Kostantinis S, Alexandrou M, et al
    International survey of chronic total occlusion percutaneous coronary intervention operators.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30914.
    PubMed     Abstract available


  65. SHARMA S, Nakamura M
    Percutaneous treatment of mechanical mitral valve thrombosis.
    Catheter Cardiovasc Interv. 2023 Nov 16. doi: 10.1002/ccd.30900.
    PubMed     Abstract available


  66. SANZ SANCHEZ J, Regazzoli D, Barbanti M, Fiorina C, et al
    Impact of balloon post-dilation on valve durability and long-term clinical outcomes after self-expanding transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Nov 13. doi: 10.1002/ccd.30907.
    PubMed     Abstract available


  67. MAJEED H, Blankenship JC
    Ellis type 4 coronary artery perforation during percutaneous coronary intervention: Case series and review.
    Catheter Cardiovasc Interv. 2023 Nov 10. doi: 10.1002/ccd.30873.
    PubMed     Abstract available


  68. NUMASAWA Y, Sawano M, Ishii H, Kohsaka S, et al
    One-year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J-PCI OUTCOME registry.
    Catheter Cardiovasc Interv. 2023 Nov 9. doi: 10.1002/ccd.30895.
    PubMed     Abstract available


  69. LIU X, Zhang Y, Xu Y, Tang Z, et al
    Fractional flow reserve versus intravascular imaging to guide decision-making for percutaneous coronary intervention in intermediate lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2023 Nov 8. doi: 10.1002/ccd.30909.
    PubMed     Abstract available


  70. COZZI O, Maurina M, Cacia M, Bernardini V, et al
    Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery.
    Catheter Cardiovasc Interv. 2023 Nov 7. doi: 10.1002/ccd.30903.
    PubMed     Abstract available


  71. ALADIN AI, Wermers JP, Zhang C, Case BC, et al
    Prognostic implication of hemoglobin reduction with and without clinical bleeding after percutaneous coronary intervention in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Nov 5. doi: 10.1002/ccd.30896.
    PubMed     Abstract available


  72. MCCABE JM, Helmy T
    Balloon-assisted leaflet modification: Gaining momentum with innovative approaches.
    Catheter Cardiovasc Interv. 2023;102:962-963.
    PubMed    


  73. ZAHR F, Lantz G
    Bi-cuspid TAVR; bye or buy!
    Catheter Cardiovasc Interv. 2023;102:960-961.
    PubMed    


  74. WILLEMEN Y, De Backer O
    Stroke prevention in TAVR: A patient-tailored approach may be needed.
    Catheter Cardiovasc Interv. 2023;102:964-965.
    PubMed    


  75. RISSANEN TT, Kleber FX, Scheller B
    Drug-coated balloon angioplasty is a well-established treatment and in everyday use in cathlabs worldwide.
    Catheter Cardiovasc Interv. 2023;102:912-913.
    PubMed    


  76. RESTIVO A, Stanzione A, Maffeo D, Buono A, et al
    Ping-pong snaring of a totally dislodged stent across left main ostium: "All is not lost".
    Catheter Cardiovasc Interv. 2023;102:889-891.
    PubMed     Abstract available


  77. TAN BE, Hashem A, Boppana LKT, Mohamed MS, et al
    Utility of rapid atrial pacing before and after TAVR with balloon-expandable valve in predicting permanent pacemaker implantation.
    Catheter Cardiovasc Interv. 2023;102:919-928.
    PubMed     Abstract available


  78. HERRMANN HC
    Hemodynamics after TAVR matter.
    Catheter Cardiovasc Interv. 2023;102:944-945.
    PubMed    


  79. LEONE PP, Regazzoli D, Pagnesi M, Costa G, et al
    Prosthesis-patient mismatch after transcatheter implantation of contemporary balloon-expandable and self-expandable valves in small aortic annuli.
    Catheter Cardiovasc Interv. 2023;102:931-943.
    PubMed     Abstract available


  80. BLACHUTZIK F, Meier S, Weissner M, Schlattner S, et al
    Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.
    Catheter Cardiovasc Interv. 2023;102:823-833.
    PubMed     Abstract available


  81. EL KHOURY A, Lazar L, Cortese B
    The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.
    Catheter Cardiovasc Interv. 2023;102:979-986.
    PubMed     Abstract available


  82. SANDESARA PB, Elhage Hassan M, Shekiladze N, Turk AA, et al
    Intravascular lithotripsy compared to rotational atherectomy for the treatment of calcified distal left main coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2023;102:997-1003.
    PubMed     Abstract available


  83. UEDA H, Fujiwara Y, Nishida Y, Maenaka M, et al
    Impact of prolonged drug-coated balloon inflation on residual stenosis and clinical outcomes in coronary artery disease patients: A propensity score matched analysis.
    Catheter Cardiovasc Interv. 2023;102:969-978.
    PubMed     Abstract available


  84. GORLA R, Tua L, D'Errigo P, Barbanti M, et al
    Incidence and predictors of 30-day and 6-month stroke after TAVR: Insights from the multicenter OBSERVANT II study.
    Catheter Cardiovasc Interv. 2023;102:1122-1131.
    PubMed     Abstract available


  85. CRITCHFIELD DR, Chamberlain RC, Turek JW, Fleming GA, et al
    Hybrid approach to pulmonary vein stenting after Fontan palliation.
    Catheter Cardiovasc Interv. 2023;102:1095-1100.
    PubMed     Abstract available


  86. STEINBERG ZL, Cabalka AK, Balzer DT, Asnes JD, et al
    Right ventricular outflow tract obstruction associated with neointimal tissue accumulation and distortion of the Harmony TPV25 stent frame: Potential mechanisms and treatment.
    Catheter Cardiovasc Interv. 2023;102:1078-1087.
    PubMed     Abstract available


  87. MERINOPOULOS I, Gunawardena T, Corballis N, Tsampasian V, et al
    Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
    Catheter Cardiovasc Interv. 2023;102:987-996.
    PubMed     Abstract available


    October 2023
  88. SHIMAMURA J, Takemoto S, Fukuhara S, Miyamoto Y, et al
    Long-term outcomes after transcatheter aortic valve replacement: Meta-analysis of Kaplan-Meier-derived data.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30854.
    PubMed     Abstract available


  89. SAVVOULIDIS P, Nadir AM, Mechery A, Lawton E, et al
    Routine postaccess-closure angiography to detect vascular complications following transfemoral TAVR.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30894.
    PubMed     Abstract available


  90. GEISLER T, Schreieck J, Euper M, Zdanyte M, et al
    Outcomes of patients undergoing edge-to-edge mitral valve repair with the Edwards PASCAL transcatheter valve repair system under conscious sedation.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30866.
    PubMed     Abstract available


  91. WONG N, Fowler D, Lim DS
    Mitral valve-in-valve with 4D intracardiac echocardiography: Procedural and imaging technique.
    Catheter Cardiovasc Interv. 2023 Oct 27. doi: 10.1002/ccd.30897.
    PubMed     Abstract available


  92. MOHAMED MO, Kinnaird T, Rab ST, Zaman S, et al
    Intracoronary imaging guided percutaneous coronary intervention outcomes among individuals with cardiogenic shock.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30859.
    PubMed     Abstract available


  93. VELAGAPUDI P, Turagam MK
    Utility of rapid atrial pacing before and after transcatheter aortic valve replacement to predict permanent pacemaker implantation: A valuable piece of the puzzle?
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30880.
    PubMed    


  94. LU H, Hu Y, Ma Y, Zhou Y, et al
    Exploring indicators of success in chronic total occlusion percutaneous coronary intervention with Stingray system-based antegrade dissection re-entry: Insights from retrospective analysis.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30889.
    PubMed     Abstract available


  95. CORTESE B, Kalkat H, Bathia G, Basavarajaiah S, et al
    The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30891.
    PubMed     Abstract available


  96. MAGYARI B, Kittka B, Gojak I, Kasza G, et al
    Single center experience with the balloon-expandable Myval transcatheter aortic valve system with the first 100 patients: 30-day and 1-year follow-up.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30868.
    PubMed     Abstract available


  97. LORIA JRD, Abdelhafez A, Desch S, Thiele H, et al
    Transcatheter aortic valve implantation in patients with anomalous origin of a coronary artery.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30860.
    PubMed     Abstract available


  98. NILSSON K, Buccheri S, Lindback J, Sarno G, et al
    External validation of the Netherlands Heart Registration (NHR) prediction model for early mortality after transcatheter aortic valve implantation (TAVI).
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30887.
    PubMed    


  99. SKALIDIS I, Hamilos M, Petousis S, Kochiadakis G, et al
    Successful closure of transcatheter aortic valve replacement-induced Gerbode defect with valve-in-valve technique: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30882.
    PubMed     Abstract available


  100. MITSUI K, Takagi K, Kakuta T, Noguchi T, et al
    Novel percutaneous intervention technique for obstructed coronary artery after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30865.
    PubMed     Abstract available


  101. MAURINA M, Chiarito M, Leone PP, Testa L, et al
    Randomized clinical trial of abluminus DES+ sirolimus-eluting stent versus everolimus-eluting DES for percutaneous coronary intervention in patients with diabetes mellitus: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30853.
    PubMed     Abstract available


  102. WONG N, Lim DS, Yount K, Yarboro L, et al
    Preemptive alcohol septal ablation prior to transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30879.
    PubMed     Abstract available


  103. AL MAWED M, Vlachojannis M, Pula A, Gielen S, et al
    Delayed coronary perforation four days after percutaneous coronary intervention with subsequent cardiac tamponade: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30861.
    PubMed     Abstract available


  104. SPILIAS N, Miyasaka R, Kapadia SR, Krishnaswamy A, et al
    A novel method of prosthetic leaflet modification to enable transcatheter mitral valve-in-valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30872.
    PubMed     Abstract available


  105. KLEBER FX
    Commentary: Dissection still a sticking point in the widespread use of DCB in PCI.
    Catheter Cardiovasc Interv. 2023;102:772-773.
    PubMed    


    September 2023
  106. SHAMKHANI W, Moledina S, Rashid M, Mamas MA, et al
    Complex high-risk percutaneous coronary intervention types, trends, and outcomes according to vascular access site.
    Catheter Cardiovasc Interv. 2023 Sep 26. doi: 10.1002/ccd.30846.
    PubMed     Abstract available


  107. BARRETT CD, Nickel A, Rosenberg MA, Ream K, et al
    PRIME score for prediction of permanent pacemaker implantation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Sep 21. doi: 10.1002/ccd.30845.
    PubMed     Abstract available


  108. SOUD M, Feit F, Rao S, Bangalore S, et al
    Novel approach to stenting the left anterior descending coronary artery through a retrograde approach via the left internal mammary artery graft in a patient with occlusion of the coronary ostium from a prior aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30844.
    PubMed     Abstract available


  109. ROTH N, Heidel C, Xu C, Hubauer U, et al
    Restoration of von Willebrand factor after transcatheter aortic valve replacement-A possible cause for posttranscatheter aortic valve replacement thrombocytopenia?
    Catheter Cardiovasc Interv. 2023 Sep 20. doi: 10.1002/ccd.30841.
    PubMed     Abstract available


  110. DI MAIO M, Esposito L, Silverio A, Bellino M, et al
    Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 13. doi: 10.1002/ccd.30842.
    PubMed     Abstract available


  111. ULLAH W, Sarvepalli D, Kumar A, Zahid S, et al
    Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30832.
    PubMed     Abstract available


  112. HOLZAMER A, Bedogni F, van Wyk P, Barwad P, et al
    Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in patients with extremely large aortic annuli in real-world scenario: First global, multicenter experience.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30820.
    PubMed     Abstract available


  113. AHN J, Yu H, Rha SW, Choi BG, et al
    Long-term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30829.
    PubMed     Abstract available


  114. REMPAKOS A, Kostantinis S, Simsek B, Karacsonyi J, et al
    Impact of preprocedural anemia on in-hospital and follow-up outcomes of chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30810.
    PubMed     Abstract available


  115. HIRAI T, Grantham JA, Kandzari DE, Ballard W, et al
    Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30834.
    PubMed     Abstract available


  116. ALEXANDROU M, Rempakos A, Al Ogaili A, Choi JW, et al
    Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30830.
    PubMed     Abstract available


  117. SOMSEN YBO, de Winter RW, Giunta R, Schumacher SP, et al
    Collateral grading systems in retrograde percutaneous coronary intervention of chronic total occlusions.
    Catheter Cardiovasc Interv. 2023 Sep 6. doi: 10.1002/ccd.30812.
    PubMed     Abstract available


  118. BRUNO F, Kang J, Elia E, Han JK, et al
    Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30802.
    PubMed     Abstract available


  119. FIORINA C, Massussi M, Ancona M, Montorfano M, et al
    Mid-term outcomes and hemodynamic performance of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: Insights from the bicuSpid TAvi duraBILITY (STABILITY) registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30813.
    PubMed     Abstract available


  120. HOKKEN TW, Wienemann H, Dargan J, Ginkel DV, et al
    Clinical value of CT-derived simulations of transcatheter-aortic-valve-implantation in challenging anatomies the PRECISE-TAVI trial.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30816.
    PubMed     Abstract available


  121. TRIANTAFYLLIS AS, Desmet W, Tonino PAL
    Diagnosing aberrant circumflex artery prior to transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30819.
    PubMed    


  122. VAZQUEZ DJL, Lopez GA, Guzman MQ, Cancelo AV, et al
    Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Catheter Cardiovasc Interv. 2023;102:513-520.
    PubMed     Abstract available


    August 2023
  123. KUNA C, Wiedenmayer N, Bradaric C, Presch A, et al
    Ten-year outcomes after percutaneous coronary intervention of in-stent restenosis in saphenous vein grafts.
    Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30807.
    PubMed     Abstract available


  124. GUPTA R, Mahmoudi E, Behnoush AH, Malik AH, et al
    Clinical outcomes and the impact of valve morphology for transcatheter aortic valve replacement in bicuspid aortic valves: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Aug 21. doi: 10.1002/ccd.30808.
    PubMed     Abstract available


  125. HAMADA S, Ueyama H, Aikawa T, Kampaktsis PN, et al
    Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2023 Aug 14. doi: 10.1002/ccd.30806.
    PubMed     Abstract available


  126. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Incidence, mechanisms, treatment, and outcomes of donor vessel injury during percutaneous coronary interventions for chronic total occlusion.
    Catheter Cardiovasc Interv. 2023 Aug 10. doi: 10.1002/ccd.30798.
    PubMed     Abstract available


  127. SUZUKI N
    Prediction of residual ischemia after coronary stenting by quantitative flow ratio modulated by optical coherence tomography: Where we are now and our future perspectives.
    Catheter Cardiovasc Interv. 2023;102:392-393.
    PubMed    


  128. ZAHR F, Chadderdon S
    Long-term results of M-TEER: A mountain of data with gaps to cross.
    Catheter Cardiovasc Interv. 2023;102:400-401.
    PubMed    


  129. LONG Y, Li W, Chen S, Li M, et al
    Novel arm-width-expandable transcatheter edge-to-edge repair system: Preclinical experiment and first-in-human study.
    Catheter Cardiovasc Interv. 2023;102:301-309.
    PubMed     Abstract available


    July 2023
  130. GROGER M, Zeiml KP, Schneider LM, Rottbauer W, et al
    Impact of concomitant tricuspid regurgitation on outcome after edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2023 Jul 28. doi: 10.1002/ccd.30787.
    PubMed     Abstract available


  131. ZHENG HJ, Yan CJ, Lin DQ, Cheng YB, et al
    Prognostic impact of new permanent pacemaker implantation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30788.
    PubMed     Abstract available


  132. KANDZARI DE, Garcia-Garcia HM, Stoler RC, Wang J, et al
    Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30783.
    PubMed     Abstract available


  133. ELBADAWI A, Dang AT, Hamed M, Ali A, et al
    Transcatheter edge-to-edge repair for mitral regurgitation using PASCAL or MitraClip.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30772.
    PubMed     Abstract available


  134. GINETE WL, Groth NA, Rudeck MN, Renier CM, et al
    Outcomes of same-day discharge following percutaneous coronary intervention in a rural population.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30762.
    PubMed     Abstract available


  135. PARK DY, An S, Jolly N, Attanasio S, et al
    Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30784.
    PubMed     Abstract available


  136. AIJAZ B, Glorioso TJ, Butala N, Waldo SW, et al
    Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30782.
    PubMed    


  137. SONODA S, Node K
    Fighting calcification with optical coherence tomography-guided percutaneous coronary intervention. Commentary on the optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30776.
    PubMed    


  138. KANE J, Kearney KE, Lombardi WL, Azzalini L, et al
    Electrocautery-assisted re-entry to resolve bilateral aorto-ostial chronic total occlusions due to leaflet obstruction following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30781.
    PubMed     Abstract available


  139. GHIZZONI G, Ancona MB, Romano V, Bellini B, et al
    Mind the "commissural drop" when crossing the aortic valve!
    Catheter Cardiovasc Interv. 2023 Jul 18. doi: 10.1002/ccd.30763.
    PubMed    


  140. NATALIS A, Masson JB, Mansour MJ, Asmar MA, et al
    Correlation between measured and predicted mismatch with valve hemodynamics in transcatheter aortic valve replacement: A sex-based analysis.
    Catheter Cardiovasc Interv. 2023 Jul 14. doi: 10.1002/ccd.30764.
    PubMed     Abstract available


  141. ZAMORANO JL, Appleby C, Benamer H, Frankenstein L, et al
    Improving access to transcatheter aortic valve implantation across Europe by restructuring cardiovascular services: An expert council consensus statement.
    Catheter Cardiovasc Interv. 2023 Jul 11. doi: 10.1002/ccd.30760.
    PubMed     Abstract available


  142. FAROUK H, Schone D, Witt C, Bayyud H, et al
    Papillary muscle rupture after transcatheter aortic valve implantation: A case report and literature review.
    Catheter Cardiovasc Interv. 2023 Jul 7. doi: 10.1002/ccd.30761.
    PubMed     Abstract available


  143. LANG FM, Mihatov N, Kriegel J, Nazif TM, et al
    Transcatheter aortic valve-in-valve implantation within stentless landing zones: Procedural insights from a single-center experience.
    Catheter Cardiovasc Interv. 2023 Jul 2. doi: 10.1002/ccd.30755.
    PubMed     Abstract available


  144. MITSUI K, Lee T, Miyazaki R, Hara N, et al
    Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Catheter Cardiovasc Interv. 2023;102:11-17.
    PubMed     Abstract available


    June 2023
  145. BLANKE P, Modine T, Duncan A, Taramasso M, et al
    Anatomic suitability for transapical transcatheter mitral valve implantation using a tether-based device.
    Catheter Cardiovasc Interv. 2023 Jun 24. doi: 10.1002/ccd.30752.
    PubMed     Abstract available


  146. REZKALLA J, Reddy Y, Nishimura RA, Padang R, et al
    Right heart catheterization predictors of symptomatic improvement in patients undergoing transcatheter tricuspid valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 Jun 23. doi: 10.1002/ccd.30754.
    PubMed     Abstract available


  147. YOKOYAMA H, Ochiai T, Saito S
    Infective endocarditis after transcatheter edge-to-edge repair for severe mitral regurgitation; a case report and a systematic review.
    Catheter Cardiovasc Interv. 2023 Jun 21. doi: 10.1002/ccd.30751.
    PubMed     Abstract available


  148. PICCOLO R, Leone A, Simonetti F, Avvedimento M, et al
    Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jun 19. doi: 10.1002/ccd.30749.
    PubMed     Abstract available


  149. LOPEZ-MINGUEZ JR, Martin de Francisco AL, Soler MJ, Hernandez F, et al
    Cost-effectiveness analysis of dyevert Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain.
    Catheter Cardiovasc Interv. 2023 Jun 10. doi: 10.1002/ccd.30744.
    PubMed     Abstract available


  150. AURIGEMMA C, Trani C, D'Errigo P, Barbanti M, et al
    Impact of vascular complications after transcatheter aortic valve implantation. VASC-OBSERVANT II sub-study.
    Catheter Cardiovasc Interv. 2023 Jun 2. doi: 10.1002/ccd.30695.
    PubMed     Abstract available


  151. DE LA TORRE HERNANDEZ JM, Veiga Fernandez G, Barrera S, Sainz Laso F, et al
    Intraprocedural delayed reassessment of paravalvular regurgitation in TAVR significantly reduces the use of postdilatation.
    Catheter Cardiovasc Interv. 2023;101:1214-1220.
    PubMed     Abstract available


  152. PERSHAD A
    CTO revascularization in TAVR patients-The jury is still out.
    Catheter Cardiovasc Interv. 2023;101:1229.
    PubMed    


  153. MERDLER I, Bernardo NL, Ben-Dor I, Waksman R, et al
    Cutting balloon for femoral arterial and venus obstructions due to suture-based closure devices: Case series.
    Catheter Cardiovasc Interv. 2023;101:1235-1238.
    PubMed     Abstract available


    May 2023
  154. WOLFRUM M, Moccetti F, Loretz L, Bossard M, et al
    Cerebral embolic protection during transcatheter aortic valve replacement: Insights from a consecutive series with the Sentinel cerebral protection device.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30697.
    PubMed     Abstract available


  155. DE FILIPPO O, Bruno F, Pinxterhuis TH, Gasior M, et al
    Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30696.
    PubMed     Abstract available


  156. DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
    Postprocedural trans-mitral gradient in patients with degenerative mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30698.
    PubMed     Abstract available


  157. RJOOB K, McGilligan V, McAllister R, Bond R, et al
    What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30684.
    PubMed     Abstract available


  158. HO CB, Vejlstrup NG, De Backer O, Sondergaard L, et al
    Intracardiac echocardiogram to diagnose infective endocarditis after transcatheter aortic valve-in-valve implantation.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30694.
    PubMed     Abstract available


  159. OKSNES A, Skaar E, Engan B, Bleie O, et al
    Effectiveness, safety, and patient reported outcomes of a planned investment procedure in higher-risk chronic total occlusion percutaneous coronary intervention: Rationale and design of the invest-CTO study.
    Catheter Cardiovasc Interv. 2023 May 17. doi: 10.1002/ccd.30692.
    PubMed     Abstract available


  160. SPARGIAS K, Lim DS, Makkar R, Kar S, et al
    Three-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study.
    Catheter Cardiovasc Interv. 2023 May 13. doi: 10.1002/ccd.30686.
    PubMed     Abstract available


  161. DING D, Tu S, Li Y, Li C, et al
    Quantitative flow ratio modulated by intracoronary optical coherence tomography for predicting physiological efficacy of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30681.
    PubMed     Abstract available


  162. GHETTI G, Bendandi F, Donati F, Ciurlanti L, et al
    Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30688.
    PubMed     Abstract available


  163. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30680.
    PubMed     Abstract available


  164. HAMEED I, Ahmed A, Kumar A, Li E, et al
    Mild aortic insufficiency following transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30674.
    PubMed     Abstract available


  165. ZHANG YJ, Ma WR, Xu B, Huang ZH, et al
    Retrograde percutaneous coronary intervention of chronic total occlusion via discontinuous septal channels.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30678.
    PubMed     Abstract available


  166. CALI F, Pagnesi M, Pezzola E, Montisci A, et al
    Transcatheter edge-to-edge mitral valve repair for post-myocardial infarction papillary muscle rupture and acute heart failure: A systematic review.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30682.
    PubMed     Abstract available


  167. CADER A, Alasnag M
    Is there a woman paradox? Commentary on the Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 May 8. doi: 10.1002/ccd.30672.
    PubMed    


  168. BUCKLEY AJ, Hensey M, O'Connor S, Maree A, et al
    Dental screening prior to transcatheter versus surgical aortic valve replacement: International Survey of Current Practices.
    Catheter Cardiovasc Interv. 2023 May 7. doi: 10.1002/ccd.30675.
    PubMed    


  169. MUSTAFA U, Helmy T
    TAVR for all-Is it time?
    Catheter Cardiovasc Interv. 2023;101:1174-1175.
    PubMed    


  170. FELDMAN D, Cao D, Sartori S, Zhang Z, et al
    Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2023;101:1134-1143.
    PubMed     Abstract available


  171. SAMIMI S, Chavez Ponce A, Alarouri HS, Shaer AE, et al
    Predictors of hemodynamic response to mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023;101:1120-1127.
    PubMed     Abstract available


  172. MASSUSSI M, Adamo M, Rosati F, Chizzola G, et al
    Coronary artery disease and TAVI: Current evidence on a recurrent issue.
    Catheter Cardiovasc Interv. 2023;101:1154-1160.
    PubMed     Abstract available


  173. YIN J, Wang R, Chen H, Lu H, et al
    In vivo evaluation of intravascular lithotripsy in a healthy porcine coronary model.
    Catheter Cardiovasc Interv. 2023;101:1062-1070.
    PubMed     Abstract available


  174. SETO AH
    Cut, score, press, shock, or ablate?
    Catheter Cardiovasc Interv. 2023;101:975-977.
    PubMed    


    April 2023
  175. YESANTHARAO PS, Etchill EW, Zhou AL, Ong CS, et al
    The impact of a statewide payment reform on transcatheter aortic valve replacement (TAVR) utilization and readmissions.
    Catheter Cardiovasc Interv. 2023 Apr 27. doi: 10.1002/ccd.30670.
    PubMed     Abstract available


  176. SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
    Computed tomography-derived membranous septum length as predictor of conduction abnormalities and permanent pacemaker implantation after TAVI: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2023 Apr 18. doi: 10.1002/ccd.30666.
    PubMed     Abstract available


  177. HOSSEINI M, Lahr BD, Greason KL, Arghami A, et al
    Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion.
    Catheter Cardiovasc Interv. 2023 Apr 10. doi: 10.1002/ccd.30658.
    PubMed     Abstract available


  178. HANNAN EL, Zhong Y, Cozzens K, Osinaga A, et al
    Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York.
    Catheter Cardiovasc Interv. 2023 Apr 1. doi: 10.1002/ccd.30648.
    PubMed     Abstract available


  179. GRINES CL, Tummala PE
    Calcified coronary nodule: Tip of the iceberg on a road full of thorns.
    Catheter Cardiovasc Interv. 2023;101:959-960.
    PubMed    


  180. HADDAD RN, Dautry R, Bonnet D, Malekzadeh-Milani S, et al
    Transvenous retrograde thoracic duct embolization for effective treatment of recurrent plastic bronchitis after fontan palliation.
    Catheter Cardiovasc Interv. 2023;101:863-869.
    PubMed     Abstract available


    March 2023
  181. TORABI AJ, Von der Lohe E, Kovacs RJ, Frick KA, et al
    Measures of social deprivation and outcomes after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30642.
    PubMed     Abstract available


  182. MEIJERINK F, Holierook M, Eberl S, Robbers-Visser D, et al
    Dobutamine stress echocardiography during transcatheter edge-to-edge mitral valve repair predicts residual mitral regurgitation.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30645.
    PubMed     Abstract available


  183. SIMSEK B, Khatri J, Young L, Kostantinis S, et al
    Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Mar 24. doi: 10.1002/ccd.30644.
    PubMed     Abstract available


  184. MORI H, Kurita T, Takasaki A, Dohi K, et al
    Plaque characterization of a saphenous vein graft by near-infrared spectroscopy and histopathology in a patient with a percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30641.
    PubMed     Abstract available


  185. HILLEGASS WB
    Vascular closure after transfemoral transcatheter aortic valve replacement: Further randomized trials are justified.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30640.
    PubMed    


  186. RYAN N, Alasnag M
    Commentary on "Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry".
    Catheter Cardiovasc Interv. 2023 Mar 21. doi: 10.1002/ccd.30643.
    PubMed    


  187. ALLANA SS, Brilakis ES
    What is the role of drug-coated balloons in chronic total occlusion percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30632.
    PubMed    


  188. ALI N, Hildick-Smith D, Parker J, Malkin CJ, et al
    Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30627.
    PubMed     Abstract available


  189. AVRAN A, Zuffi A, Gobbi C, Gasperetti A, et al
    Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30616.
    PubMed     Abstract available


  190. POSTALIAN A, Krajcer Z
    The relationship between chronic kidney disease and "complex" percutaneous coronary intervention: Uncovering the details.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30612.
    PubMed    


  191. LEE A, Gilchrist IC
    A tale of two registries: Trends and outcomes of percutaneous coronary intervention in two transatlantic populations.
    Catheter Cardiovasc Interv. 2023 Mar 2. doi: 10.1002/ccd.30608.
    PubMed    


  192. UEYAMA H, Block PC
    Can patients be selected for transcatheter edge-to-edge repair based on the baseline transmitral gradient?
    Catheter Cardiovasc Interv. 2023;101:830-831.
    PubMed    


  193. HEUSER RR
    Regulators can we get DCB balloons approved for use in the United States?
    Catheter Cardiovasc Interv. 2023;101:834-835.
    PubMed    


  194. MANGIERI A, Nerla R, Castriota F, Reimers B, et al
    Cutting balloon to optimize predilation for stent implantation: The COPS randomized trial.
    Catheter Cardiovasc Interv. 2023;101:798-805.
    PubMed     Abstract available


    February 2023
  195. UENO K, Morita N, Kojima Y, Takahashi H, et al
    Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Feb 25. doi: 10.1002/ccd.30598.
    PubMed     Abstract available


  196. IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
    Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized t
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30600.
    PubMed     Abstract available


  197. HEATON J, Singh S, Nanavaty D, Okoh AK, et al
    Impact of frailty on outcomes in acute ST-elevated myocardial infarctions undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30595.
    PubMed     Abstract available


  198. WILL M, Schwarz K, Weiss T, Leibundgut G, et al
    The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30601.
    PubMed     Abstract available


  199. SEDHOM R, Dang AT, Elwagdy A, Megaly M, et al
    Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30597.
    PubMed     Abstract available


  200. REMPAKOS A, Simsek B, Kostantinis S, Karacsonyi J, et al
    Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30581.
    PubMed     Abstract available


  201. KOSTANTINIS S, Simsek B, Karacsonyi J, Rempakos A, et al
    Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30580.
    PubMed     Abstract available


  202. NATANZON SS, Koseki K, Kaewkes D, Koren O, et al
    Society of thoracic surgeons risk score and left atrial pressure for predicting clinical outcomes among transcatheter mitral edge-to-edge repair patients.
    Catheter Cardiovasc Interv. 2023;101:596-604.
    PubMed     Abstract available


  203. ARUNOTHAYARAJ S, Lassen JF, Clesham GJ, Spence MS, et al
    Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial.
    Catheter Cardiovasc Interv. 2023;101:553-562.
    PubMed     Abstract available


  204. ERDEM S, An SY, McAlister CA, Basra SS, et al
    Suicide left ventricle following protamine: A case report.
    Catheter Cardiovasc Interv. 2023;101:592-595.
    PubMed     Abstract available


    January 2023
  205. LUGO-FAGUNDO N, Pierre K, Adedinsewo D, Simard T, et al
    The impact of baseline transmitral diastolic mean gradient on left atrial pressure reduction in patients undergoing transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2023 Jan 30. doi: 10.1002/ccd.30577.
    PubMed     Abstract available


  206. ALVAREZ-COVARRUBIAS HA, Joner M, Cassese S, Warmbrunn M, et al
    Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease.
    Catheter Cardiovasc Interv. 2023 Jan 29. doi: 10.1002/ccd.30576.
    PubMed     Abstract available


  207. HIRUMA T, Higuchi R, Saji M, Takamisawa I, et al
    Transcatheter aortic valve replacement-related aortic dissection: A clinical case series.
    Catheter Cardiovasc Interv. 2023 Jan 26. doi: 10.1002/ccd.30574.
    PubMed     Abstract available


  208. KARACSONYI J, Alaswad K, Krestyaninov O, Karmpaliotis D, et al
    Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Jan 25. doi: 10.1002/ccd.30564.
    PubMed     Abstract available


  209. KAWAMURA Y, Yoshimachi F, Kasai S, Ikari Y, et al
    Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30568.
    PubMed     Abstract available


  210. CHEN H, Spirito A, Sartori S, Nicolas J, et al
    Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30569.
    PubMed     Abstract available


  211. RASANEN A, Karkkainen JM, Eranti A, Eranen J, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30558.
    PubMed     Abstract available


  212. AZZALINI L, Boudou N, Avran A, Kane J, et al
    Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30565.
    PubMed     Abstract available


  213. SA MP, Van den Eynde J, Jacquemyn X, Erten O, et al
    Cusp-overlap versus coplanar view in transcatheter aortic valve implantation with self-expandable valves: A meta-analysis of comparative studies.
    Catheter Cardiovasc Interv. 2023 Jan 19. doi: 10.1002/ccd.30562.
    PubMed     Abstract available


  214. MONTARELLO NJ, Quagliana A, Sondergaard L, De Backer O, et al
    Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2023 Jan 18. doi: 10.1002/ccd.30561.
    PubMed     Abstract available


  215. SAVVOULIDIS P, Nadir AM, Mechery A, Doshi SN, et al
    A very rare vascular complication of the Edwards expandable eSheath during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jan 14. doi: 10.1002/ccd.30557.
    PubMed     Abstract available


  216. ISMAYL M, Machanahalli Balakrishna A, Elgayesh MM, Thandra A, et al
    Impact of sex on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter mitral valve replacement (TMVR): Analysis from the nationwide readmission database.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30549.
    PubMed     Abstract available


  217. CHEN J, Yang Y, Song W, Feng D, et al
    Transcatheter tricuspid valve-in-valve implantation for degenerated surgical bioprosthesis.
    Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30554.
    PubMed     Abstract available


  218. DAVIS MG, Blankenship JC
    PCI for late STEMI: Better late than never?
    Catheter Cardiovasc Interv. 2023;101:11-12.
    PubMed    


  219. DOOST A, Chilmeran A, Gomes A, Dworakowski R, et al
    Single arterial access closure of post-infarction ventricular septal defect: A case series.
    Catheter Cardiovasc Interv. 2023;101:209-216.
    PubMed     Abstract available


  220. SHIBBANI K, Aboulhosn J, Levi D, Mohammad Nijres B, et al
    Hybrid approach for harmony transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2023;101:135-139.
    PubMed     Abstract available


  221. BINGEN BO, Al Amri I, Montero-Cabezas JM, van der Kley F, et al
    Bail out lithotripsy to treat delayed valve-in-valve TAVR-related coronary obstruction.
    Catheter Cardiovasc Interv. 2023;101:97-101.
    PubMed     Abstract available


    December 2022
  222. BARBOSA MOREIRA MJ, Peixoto NADA, Udoma-Udofa OC, de Araujo SLS, et al
    Direct oral anticoagulant versus antiplatelet therapy following transcatheter aortic valve replacement in patients without prior or concurrent indication for anticoagulation: A meta-analysis of randomized studies.
    Catheter Cardiovasc Interv. 2022 Dec 27. doi: 10.1002/ccd.30532.
    PubMed     Abstract available


  223. ISOGAI T, Agrawal A, Shekhar S, Spilias N, et al
    One-year clinical and echocardiographic outcomes of transcatheter aortic valve replacement with SAPIEN 3 Ultra versus SAPIEN 3.
    Catheter Cardiovasc Interv. 2022 Dec 13. doi: 10.1002/ccd.30515.
    PubMed     Abstract available


  224. ROUT A, Sharma A, Ikram S, Garg A, et al
    Short-term dual antiplatelet therapy for 1-3 months after percutaneous coronary intervention using drug eluting stents: A systematic review and meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2022 Dec 9. doi: 10.1002/ccd.30521.
    PubMed     Abstract available


  225. QIAN J, Wu Y, Li C, Yin J, et al
    Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
    Catheter Cardiovasc Interv. 2022 Dec 8. doi: 10.1002/ccd.30472.
    PubMed     Abstract available


  226. ZAID S, Haniyeh AA, Rosenzveig A, Malik A, et al
    Minimalist transcatheter aortic valve replacement misses paravalvular regurgitation: Incidence and echocardiographic distribution of missed paravalvular regurgitation.
    Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30512.
    PubMed     Abstract available


  227. OGAMI T, Kliner DE, Toma C, Serna-Gallegos D, et al
    Readmission with infective endocarditis within 90 days following transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Dec 7. doi: 10.1002/ccd.30508.
    PubMed     Abstract available


  228. EL HAJJ M, Krajcer Z
    Percutaneous tricuspid valve repair: A safer alternative to traditional approaches?
    Catheter Cardiovasc Interv. 2022;100:1300-1301.
    PubMed    


  229. MICHAIL M, Cockburn J, Tanseco KVP, Arunothayaraj S, et al
    Feasibility of transcaval access TAVI in morbidly obese patients: A single-center experience.
    Catheter Cardiovasc Interv. 2022;100:1302-1306.
    PubMed     Abstract available


  230. TOMII D, Okuno T, Lanz J, Stortecky S, et al
    Aortic annulus ellipticity and outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Dec 1. doi: 10.1002/ccd.30507.
    PubMed     Abstract available


    November 2022
  231. TANNER R, Murphy S, Malone C, McGorrian C, et al
    Correlation of aortic valve annular plane assessment by on-table three-dimensional rotational angiography and preprocedural computed tomography.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30469.
    PubMed     Abstract available


  232. NG JCK, Ang H, Zhong L, Hakim D, et al
    Multimodality imaging results of TAP versus novel modified TAP stenting in coronary bifurcation: From bench testing to first-in-man investigation.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30496.
    PubMed     Abstract available


  233. AZZALINI L, Moroni F, Dawson KL, Kearney KE, et al
    Chronic total occlusion percutaneous coronary intervention in heart transplant patients.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30476.
    PubMed     Abstract available


  234. SAMMOUR YM, Lak H, Chahine J, Abushouk A, et al
    Clinical and echocardiographic outcomes with new-onset left bundle branch block after SAPIEN-3 transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30488.
    PubMed     Abstract available


  235. BALDUS S, Schofer N, Hausleiter J, Friedrichs K, et al
    Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30-day results.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30450.
    PubMed     Abstract available


  236. NAGRAJ S, Tzoumas A, Kakargias F, Giannopoulos S, et al
    Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients.
    Catheter Cardiovasc Interv. 2022 Nov 6. doi: 10.1002/ccd.30446.
    PubMed     Abstract available


  237. SELVARAJ V, Chatterjee S, Hirai T, Abbott JD, et al
    Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2022 Nov 3. doi: 10.1002/ccd.30467.
    PubMed     Abstract available


  238. LEE HJ, Mejia-Renteria H, Escaned J, Doh JH, et al
    Prediction of functional results of percutaneous coronary interventions with virtual stenting and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30451.
    PubMed     Abstract available


  239. MEREDITH T, Scheuer S, Hoffman M, Joshi Y, et al
    Coronary angiography of the ex-situ beating donor heart in a portable organ care system.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30455.
    PubMed     Abstract available


  240. MILLER MS, Cutts J, Donatelle M, Shah K, et al
    Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30471.
    PubMed     Abstract available


  241. ABDULLA A, Jneid H
    Transcatheter therapies for severe aortic and mitral stenosis: To stage or not to stage?
    Catheter Cardiovasc Interv. 2022;100:901-902.
    PubMed    


  242. ALLANA SS, Brilakis ES
    How good is intravascular brachytherapy for treating in-stent restenosis?
    Catheter Cardiovasc Interv. 2022;100:763-764.
    PubMed    


  243. NARAYANAN A, Jneid H
    A new frontier in left atrial appendage closure.
    Catheter Cardiovasc Interv. 2022;100:929-930.
    PubMed    


  244. UEYAMA H, Block PC
    Membranous septum length may not be the answer.
    Catheter Cardiovasc Interv. 2022;100:877-878.
    PubMed    


  245. JONES EL, Blankenship JC
    Women deserve the best care.
    Catheter Cardiovasc Interv. 2022;100:936-937.
    PubMed    


  246. SATLER LF
    When possible, try to avoid emergent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;100:839-840.
    PubMed    


  247. TAYLOR A, Yang J, Dubin A, Chubb MH, et al
    Ventricular arrhythmias following transcatheter pulmonary valve replacement with the harmony TPV25 device.
    Catheter Cardiovasc Interv. 2022;100:766-773.
    PubMed     Abstract available


  248. CHAVARRIA J, Falcao F, Dutra G, Sathananthan J, et al
    Bespoke valve sizing avoids annular rupture in patients treated with a balloon-expandable transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;100:823-831.
    PubMed     Abstract available


  249. SIMSEK B, Kostantinis S, Karacsonyi J, Allana S, et al
    Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;100:749-755.
    PubMed     Abstract available


  250. CHAMI T, Mahowald MK, Brilakis E
    Retrograde approach for rewiring a jailed side branch during double kissing crush stenting.
    Catheter Cardiovasc Interv. 2022;100:756-758.
    PubMed     Abstract available


  251. SHAMEKHI J, Hasse C, Veulemans V, Al-Kassou B, et al
    A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR-A multicenter analysis.
    Catheter Cardiovasc Interv. 2022;100:850-859.
    PubMed     Abstract available


  252. WINSCOTT JG, Hillegass WB
    Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure.
    Catheter Cardiovasc Interv. 2022;100:747-748.
    PubMed    


  253. UEYAMA H, Block PC
    Data are data: Do we need a randomized trial of transcatheter aortic valve replacement for bicuspid valves?
    Catheter Cardiovasc Interv. 2022;100:1132-1133.
    PubMed    


  254. SALAETS T, Cools B, De Meester P, Heying R, et al
    Stent expansion of restrictive Fontan conduits to nominal diameter and beyond.
    Catheter Cardiovasc Interv. 2022;100:1059-1066.
    PubMed     Abstract available


  255. NAGASAKA T, Amanai S, Ishibashi Y, Aihara K, et al
    Long-term outcomes of intermediate coronary stenosis in patients undergoing hemodialysis after deferred revascularization based on fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;100:971-978.
    PubMed     Abstract available


  256. ALLALI A, Toelg R, Abdel-Wahab M, Hemetsberger R, et al
    Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: The PREPARE-CALC-COMBO study.
    Catheter Cardiovasc Interv. 2022;100:979-989.
    PubMed     Abstract available


  257. PICCOLO R, Esposito G
    Peripheral arterial disease and multisite atherosclerosis in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100:1146-1147.
    PubMed    


  258. SETH A, Ezhumalai B
    Percutaneous Coronary Intervention of bifurcation lesions: The proof is in the pudding!
    Catheter Cardiovasc Interv. 2022;100:1148-1149.
    PubMed    


  259. ALLANA SS, Brilakis ES
    Why complex and high risk percutaneous coronary interventions should be offered to selected octogenarians/nonagenarians.
    Catheter Cardiovasc Interv. 2022;100:1143-1145.
    PubMed    


  260. BUCCOLA J, Meinen J, Spinelli J, Hammerstone M, et al
    Investigating real-world impact of optical coherence tomography workflow-guided coronary interventions: Design and rationale of the LightLab Clinical Initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S1-S6.
    PubMed     Abstract available


  261. SHLOFMITZ E, Croce K, Bezerra H, Sheth T, et al
    The MLD MAX OCT algorithm: An imaging-based workflow for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S7-S13.
    PubMed     Abstract available


  262. KHUDDUS MA, Darki A, Padaliya BB, West NEJ, et al
    Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S14-S24.
    PubMed     Abstract available


    October 2022
  263. NAIMI I, Morray B, Portman MA, Steinberg ZL, et al
    Use of the PK Papyrus covered coronary stent in the treatment of Kawasaki disease-associated giant coronary artery aneurysms.
    Catheter Cardiovasc Interv. 2022 Oct 26. doi: 10.1002/ccd.30458.
    PubMed     Abstract available


  264. KOSTANTINIS S, Simsek B, Karacsonyi J, Alaswad K, et al
    Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Oct 25. doi: 10.1002/ccd.30425.
    PubMed     Abstract available


  265. TEBAR MARQUEZ D, Moreno R, Galeote G, Jurado-Roman A, et al
    Transcatheter aortic valve with a novel self-expandable device in patients with previous mechanical mitral valve prosthesis.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30449.
    PubMed     Abstract available


  266. GERCEK M, Irimie AA, Gercek M, Fox H, et al
    Cognitive function in late-stage HFpEF patients with tricuspid regurgitation undergoing transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30443.
    PubMed     Abstract available


  267. YASHIGE M, Zen K, Takamatsu K, Matoba S, et al
    Additional balloon aortic valvuloplasty to overcome the difficult removal of a self-expandable transcatheter aortic valve system due to valve infolding.
    Catheter Cardiovasc Interv. 2022 Oct 19. doi: 10.1002/ccd.30444.
    PubMed     Abstract available


  268. SIDDIQI TJ, Khan MS, Karimi Galougahi K, Shlofmitz E, et al
    Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Oct 17. doi: 10.1002/ccd.30416.
    PubMed     Abstract available


  269. VERREAULT-JULIEN L, Shekiladze N, Wollmuth J, Rinfret S, et al
    Single-access for Impella-supported percutaneous coronary intervention using a sheathless technique with an 8 Fr guide.
    Catheter Cardiovasc Interv. 2022 Oct 13. doi: 10.1002/ccd.30427.
    PubMed     Abstract available



  270. Erratum to "Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience".
    Catheter Cardiovasc Interv. 2022 Oct 4. doi: 10.1002/ccd.30409.
    PubMed    


  271. MATHEWS SJ, Brown CL, Kolski BC, Marques VM, et al
    Initial experience with a continuous mechanical aspiration system for thrombus removal before percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30389.
    PubMed     Abstract available


  272. EARLE W, Abdallah G, Meagher S, Shen K, et al
    Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30412.
    PubMed     Abstract available


  273. ULLAH W, Zahid S, Muhammadzai H, Khalil F, et al
    Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30407.
    PubMed     Abstract available


  274. KHOKHAR AA, Giannini F, Zlahoda-Huzior A, Mikhail G, et al
    Coronary access after ACURATE neo2 implantation for valve-in-valve TAVR: Insights from ex vivo simulations.
    Catheter Cardiovasc Interv. 2022;100:662-666.
    PubMed    


  275. ZABLAH JE, Dohlen G, Ystgaard MB, Morgan GJ, et al
    Piggyback mounting for stent and valve deployment during percutaneous pulmonary valve implantation.
    Catheter Cardiovasc Interv. 2022;100:606-611.
    PubMed     Abstract available


  276. CHAMBERS JW, Martinsen BJ, Sturm RC, Mandair D, et al
    Orbital atherectomy of calcified coronary ostial lesions.
    Catheter Cardiovasc Interv. 2022;100:553-559.
    PubMed     Abstract available


    September 2022
  277. MEGALY M, Buda K, Karacsonyi J, Kostantinis S, et al
    Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30403.
    PubMed     Abstract available


  278. BASHAR H, Matetic A, Curzen N, Mamas MA, et al
    Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 21. doi: 10.1002/ccd.30404.
    PubMed     Abstract available


  279. BERKOVITCH A, Segev A, Guetta V, Finkelstein A, et al
    Procedural and long-term outcome among patients undergoing expedited trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30386.
    PubMed     Abstract available


  280. ABUSHOUK AI, Abdelfattah O, Gad MM, Saad A, et al
    Two-year outcomes after transcatheter aortic valve-in-valve implantation in degenerated surgical valves.
    Catheter Cardiovasc Interv. 2022 Sep 18. doi: 10.1002/ccd.30388.
    PubMed     Abstract available


  281. CARANDE EJ, Protty MB, Verhemel S, Hussein MH, et al
    Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.
    Catheter Cardiovasc Interv. 2022 Sep 14. doi: 10.1002/ccd.30400.
    PubMed     Abstract available


  282. ZAHR F, Chadderdon S, Song H, Sako E, et al
    Contemporary diagnosis and management of severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2022 Sep 10. doi: 10.1002/ccd.30364.
    PubMed     Abstract available


  283. HIOKI H, Watanabe Y, Kozuma K, Ryuzaki T, et al
    Validation of reliability and predictivity of membrane septum length measurements for pacemaker need after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30377.
    PubMed     Abstract available


  284. AL-FARRA H, Ravelli ACJ, Henriques JPS, Houterman S, et al
    Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI-NHR risk model.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30398.
    PubMed     Abstract available


  285. SHAMKHANI W, Rashid M, Mamas M
    Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.
    Catheter Cardiovasc Interv. 2022 Sep 2. doi: 10.1002/ccd.30366.
    PubMed     Abstract available


  286. GRINES CL, Dupont A
    Turndown for coronary artery bypass surgery: Never say never to revascularization.
    Catheter Cardiovasc Interv. 2022;100:367-368.
    PubMed     Abstract available


  287. TARANTINI G, Cardaioli F
    SAPIEN 3 transcatheter heart valve in patients with borderline annulus: "stretched better than bigger?"
    Catheter Cardiovasc Interv. 2022;100:422-423.
    PubMed    


  288. ZAHID S, Khan MZ, Ullah W, Tanveer Ud Din M, et al
    In-hospital outcomes of TAVR patients with a bundle branch block: Insights from the National Inpatient Sample 2011-2018.
    Catheter Cardiovasc Interv. 2022;100:424-436.
    PubMed     Abstract available


    August 2022
  289. SAGER R, Keller LS, Stehli J, Jakob P, et al
    Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (>/=80 years) patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30365.
    PubMed     Abstract available


  290. MAURINA M, Condello F, Mangieri A, Sanz-Sanchez J, et al
    Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30385.
    PubMed     Abstract available


  291. OKUNO T, Dangas GD, Hengstenberg C, Sartori S, et al
    Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30370.
    PubMed     Abstract available


  292. SADAT N, Bruhn D, Scharfschwerdt M, Schaller T, et al
    Impact of high-pressure balloon aortic valvuloplasty on the hydrodynamic result after a transcatheter valve-in-valve procedure.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30359.
    PubMed     Abstract available


  293. ZAJARIAS A, Kodali S, McCabe JM, Eng MH, et al
    Real-world experience with concomitant or staged transcatheter aortic and mitral valve replacements using balloon-expandable valves.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30331.
    PubMed     Abstract available


  294. SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
    Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
    PubMed     Abstract available


  295. LIU JD, Zhang SY, Wu YQ, Gong R, et al
    Valve implantation for successful sealing of a balloon predilatation-induced annular rupture during transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Aug 3. doi: 10.1002/ccd.30353.
    PubMed     Abstract available


  296. ISOGAI T, Vanguru HR, Krishnaswamy A, Agrawal A, et al
    Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30340.
    PubMed     Abstract available


  297. KOSTANTINIS S, Simsek B, Karacsonyi J, Davies RE, et al
    Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30354.
    PubMed     Abstract available


  298. ENG MH, Zahr F
    When should early discharge post-transcatheter aortic valve replacement be blocked?
    Catheter Cardiovasc Interv. 2022;100:254-255.
    PubMed    


  299. VETROVEC GW
    Robotic coronary angiography: Advantages of stepping back.
    Catheter Cardiovasc Interv. 2022;100:214-215.
    PubMed    


  300. TARANTINI G, Cardaioli F
    Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient.
    Catheter Cardiovasc Interv. 2022;100:243-244.
    PubMed    


  301. HELMY T, Mina G
    Single access TAVR. How "minimalist" do we need to be?
    Catheter Cardiovasc Interv. 2022;100:233-234.
    PubMed    


    July 2022
  302. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Antegrade dissection and re-entry versus parallel wiring in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30346.
    PubMed     Abstract available


  303. GALLITTO E, Palmerini T, Saia F, Gargiulo M, et al
    Iliac "paving & cracking" technique for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30344.
    PubMed     Abstract available


  304. SIMSEK B, Gorgulu S, Kostantinis S, Karacsonyi J, et al
    Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30347.
    PubMed     Abstract available


  305. DAUTZENBERG L, van Aarle TTM, Stella PR, Emmelot-Vonk M, et al
    The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2022 Jul 13. doi: 10.1002/ccd.30320.
    PubMed     Abstract available


  306. GALASSI AR, Vadala G, Testa G, Puglisi S, et al
    Dual guidewire balloon antegrade fenestration and re-entry technique for coronary chronic total occlusions percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30324.
    PubMed     Abstract available


  307. RUSSO M, Chen C, Sethi A, Hakeem A, et al
    TAVR in an XXXL annulus (1057 mm(2) ) with type I bicuspid aortic valve.
    Catheter Cardiovasc Interv. 2022 Jul 6. doi: 10.1002/ccd.30325.
    PubMed     Abstract available


  308. FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
    Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
    PubMed     Abstract available


  309. ALASNAG M
    Lifetime management when a redo is in the balance: Valve-in-valve transcatheter aortic valve replacement or resurgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022;100:131-132.
    PubMed    


  310. GRINES CL, Marshall JJ
    Directional coronary atherectomy revisited.
    Catheter Cardiovasc Interv. 2022;100:59-60.
    PubMed    


  311. LIANG B, Gu N
    High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
    Catheter Cardiovasc Interv. 2022;100:61-71.
    PubMed     Abstract available


  312. ASHLEY KE, Hillegass WB
    Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;100:83-84.
    PubMed    


    June 2022
  313. RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
    Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
    PubMed     Abstract available


  314. ELZANATY AM, Maraey A, Elbadawi A, Khalil M, et al
    Early versus late discharge after transcatheter aortic valve replacement and readmissions for permanent pacemaker implantation.
    Catheter Cardiovasc Interv. 2022 Jun 27. doi: 10.1002/ccd.30299.
    PubMed     Abstract available


  315. MEDRANDA GA, Rogers T, Fuery M, Case BC, et al
    Impact of left ventricular outflow tract calcium on valve geometry in self-expanding transcatheter aortic-valve replacement.
    Catheter Cardiovasc Interv. 2022 Jun 20. doi: 10.1002/ccd.30301.
    PubMed     Abstract available


  316. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    PubMed     Abstract available


  317. ARONEY NP, Patterson T, Kalogeropoulos A, Allen CJ, et al
    Clinical outcomes following single access transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30246.
    PubMed     Abstract available


  318. ROBERT P, Akodad M, Lattuca B, Gandet T, et al
    Transcatheter aortic valve implantation in patients with uninterrupted vitamin K antagonists.
    Catheter Cardiovasc Interv. 2022 Jun 5. doi: 10.1002/ccd.30248.
    PubMed     Abstract available


  319. KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
    Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
    PubMed     Abstract available


  320. TARANTINI G, Fraccaro C
    Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients-Patients' vulnerability still matters.
    Catheter Cardiovasc Interv. 2022;99:2111-2112.
    PubMed    


  321. KARACSONYI J, Brilakis ES, Chandwaney RH
    Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2022;99:2038-2042.
    PubMed     Abstract available


    May 2022
  322. DE FELICE F, Paolucci L, Musto C, Cifarelli A, et al
    Clinical outcomes and predictors in patients with previous cardiac surgery undergoing mitral valve transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30245.
    PubMed     Abstract available


  323. KLEIN LW, Anderson HV, Cigarroa J
    Integrating shared decision-making in coronary revascularization with quality assurance programs.
    Catheter Cardiovasc Interv. 2022 May 29. doi: 10.1002/ccd.30222.
    PubMed    


  324. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
    PubMed     Abstract available


  325. ALACHKAR MN, Muller T, Alnaimi A, Milzi A, et al
    Safety and efficacy of transcatheter mitral valve repair in patients with COPD; results from real-world cohort.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30238.
    PubMed     Abstract available


  326. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
    Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
    PubMed     Abstract available


  327. VAN HATTEM VAE, Otterspoor LC, Lipsic E, Vlaar PJJ, et al
    Right ventricular hematoma: A rare but potentially fatal complication of percutaneous coronary artery intervention.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30226.
    PubMed     Abstract available


  328. CORCIONE N, Berni A, Ferraro P, Morello A, et al
    Transcatheter aortic valve implantation with the novel-generation Navitor device: Procedural and early outcomes.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30179.
    PubMed     Abstract available


  329. SIMARD T, Reddy YNV, Thaden JJ, Padang R, et al
    Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 10. doi: 10.1002/ccd.30224.
    PubMed     Abstract available


  330. ONO M, Onuma Y, Kawashima H, Hara H, et al
    Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
    PubMed     Abstract available


  331. JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
    Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
    PubMed     Abstract available


  332. WANG M, Liu H, Xu B, Bian X, et al
    Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
    PubMed     Abstract available


  333. LEE A, Kimmelstiel C
    Stretching and cutting after drilling. Vessel preparation following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022;99:1750-1751.
    PubMed    


  334. POSTALIAN A, Krajcer Z
    Mitral annular calcification-A marker of risk, and a harbinger of technical challenges during intervention.
    Catheter Cardiovasc Interv. 2022;99:1817-1818.
    PubMed    


  335. TARANTINI G, Cardaioli F
    TAVR and stroke: A common evolution.
    Catheter Cardiovasc Interv. 2022;99:1906-1907.
    PubMed    


  336. PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
    Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1741-1749.
    PubMed     Abstract available


  337. SEDHOM R, Megaly M, Saad M, Elbadawi A, et al
    Transcatheter edge-to-edge repair of the tricuspid valve: The US experience.
    Catheter Cardiovasc Interv. 2022;99:1859-1866.
    PubMed     Abstract available


  338. TANG GHL, Hooda A, Zaid S, Chuang MY, et al
    Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuli.
    Catheter Cardiovasc Interv. 2022;99:1935-1944.
    PubMed     Abstract available


  339. BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
    Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
    Catheter Cardiovasc Interv. 2022;99:1752-1757.
    PubMed     Abstract available


  340. VENTURI G, Scarsini R, Pighi M, Kotronias RA, et al
    Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI.
    Catheter Cardiovasc Interv. 2022;99:1925-1934.
    PubMed     Abstract available


  341. MOHANTY BD, Coylewright M, Sequeira AR, Shin D, et al
    Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER-2.
    Catheter Cardiovasc Interv. 2022;99:1877-1885.
    PubMed     Abstract available


  342. PORAT A, Gordon M, Perlman G, Planer D, et al
    Mass to voltage ratio index predicts mortality following TAVI.
    Catheter Cardiovasc Interv. 2022;99:1918-1924.
    PubMed     Abstract available


  343. ROTTLANDER D, Beucher H, Ghaddioui KA, Boekstegers P, et al
    Continuous atrial pressure monitoring via steerable guide catheter in transcatheter mitral and tricuspid edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1796-1806.
    PubMed     Abstract available


  344. YA'QOUB L, Gad M, Faza NN, Kunkel KJ, et al
    Sex differences in outcomes of transcatheter edge-to-edge repair with MitraClip: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1819-1828.
    PubMed     Abstract available


  345. ALADIN AI, Case BC, Wermers JP, Rogers T, et al
    Overview of FDA Circulatory System Devices Panel virtual meeting on TriGUARD 3 cerebral embolic protection.
    Catheter Cardiovasc Interv. 2022;99:1789-1795.
    PubMed     Abstract available


    April 2022
  346. BRUNO F, Elia E, D'Ascenzo F, Marengo G, et al
    Valve-in-valve transcatheter aortic valve replacement or re-surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022 Apr 29. doi: 10.1002/ccd.30219.
    PubMed     Abstract available


  347. MEMON MM, Siddiqui AA, Amin E, Shaikh FN, et al
    Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Apr 27. doi: 10.1002/ccd.30213.
    PubMed     Abstract available


  348. KAWAGUCHI T, Miyoshi T, Hayashi M, Ishizu K, et al
    Efficacy of larger valve sizing with underfilling in balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30188.
    PubMed     Abstract available


  349. HOLLOWED J, Akhondi A, Rabbani A, Oncel D, et al
    Single versus double Perclose techniques for vascular closure during transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30176.
    PubMed     Abstract available


  350. BALDETTI L, Beneduce A, Boccellino A, Pagnesi M, et al
    Bedside intra-aortic balloon pump insertion in cardiac intensive care unit: A single-center experience.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30197.
    PubMed     Abstract available


  351. SALEM H, Mintz GS, Matsumura M, Zhang M, et al
    Reasons for lesion uncrossability as assessed by intravascular ultrasound.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
    PubMed     Abstract available


  352. HOU S, Pan W, Zhou D, Ge J, et al
    Percutaneous balloon mitral valvuloplasty using veno-arterial loop and neuro-embolic protection for mitral stenosis with thrombus.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30203.
    PubMed     Abstract available


  353. PIRIOU PG, Manigold T, Letocart V, Le Ruz R, et al
    Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30194.
    PubMed     Abstract available


  354. YONG CM, Jaluba K, Batchelor W, Gummipundi S, et al
    Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30182.
    PubMed     Abstract available


  355. INCI E, Block PC
    A little leak goes a long way! 5-Year-outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022;99:1590-1591.
    PubMed     Abstract available


  356. LIU X, Chen Y, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in patient with atrial functional mitral regurgitation using novel DragonFly device.
    Catheter Cardiovasc Interv. 2022;99:1691-1695.
    PubMed     Abstract available


  357. SEGAR MW, Krajcer Z
    Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap.
    Catheter Cardiovasc Interv. 2022;99:1645-1646.
    PubMed    


  358. TARANTINI G, Rodino G
    Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone.
    Catheter Cardiovasc Interv. 2022;99:1609-1610.
    PubMed    


  359. BRUCE CG, Lederman RJ
    Troubleshooting transcaval access: Honoring our commitments.
    Catheter Cardiovasc Interv. 2022;99:1700-1701.
    PubMed    


  360. BANSAL A, Jaber WA, Reed GW, Puri R, et al
    Surgical versus medical management of infective endocarditis after TAVR.
    Catheter Cardiovasc Interv. 2022;99:1592-1596.
    PubMed     Abstract available


  361. RUGE H, Burri M, Erlebach M, Lange R, et al
    Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR.
    Catheter Cardiovasc Interv. 2022;99:1611-1618.
    PubMed     Abstract available


  362. GOLDSWEIG AM, Hermiller JB
    Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
    Catheter Cardiovasc Interv. 2022;99:1597-1598.
    PubMed    


    March 2022
  363. SIMSEK B, Kostantinis S, Karacsonyi J, Hall A, et al
    International percutaneous coronary intervention complication survey.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30173.
    PubMed     Abstract available


  364. ZHU Q, Yuan Z, Xu Y, Chen J, et al
    Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30147.
    PubMed     Abstract available


  365. LE RUZ R, Guerin P, Leurent G, Leroux L, et al
    Mitral valve-in-valve and valve-in-ring procedures: Midterm outcomes in a French nationwide registry.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30161.
    PubMed     Abstract available


  366. JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
    Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
    Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
    PubMed     Abstract available


  367. ESCHENBACH LK, Erlebach M, Deutsch MA, Ruge H, et al
    Stroke after transcatheter aortic valve replacement: A severe complication with low predictability.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30143.
    PubMed     Abstract available


  368. SA MP, Jabagi H, Dokollari A, Awad AK, et al
    Early and late outcomes of surgical aortic valve replacement with sutureless and rapid-deployment valves versus transcatheter aortic valve implantation: Meta-analysis with reconstructed time-to-event data of matched studies.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30162.
    PubMed     Abstract available


  369. SANZ-SANCHEZ J, Mashayekhi K, Agostoni P, Egred M, et al
    Device entrapment during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30160.
    PubMed     Abstract available


  370. ROTTLANDER D, Golabkesh M, Degen H, Ogutcu A, et al
    Mitral valve edge-to-edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30157.
    PubMed     Abstract available


  371. VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
    Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
    PubMed     Abstract available


  372. MANO TB, Ramos R, Cacela D, Patricio L, et al
    Not all pseudoaneurysms are femoral-A transcaval transcatheter aortic valve replacement rare complication.
    Catheter Cardiovasc Interv. 2022 Mar 3. doi: 10.1002/ccd.30140.
    PubMed     Abstract available


  373. WINSCOTT JG, Hillegass WB
    Successfully treating the common femoral artery "no go zone" with directional atherectomy plus antirestenotic therapy (DAART).
    Catheter Cardiovasc Interv. 2022;99:1317-1318.
    PubMed    


  374. SPIRITO A, Mehran R
    Elderly patients with acute myocardial infarction: Targeted or complete revascularization?
    Catheter Cardiovasc Interv. 2022;99:979-980.
    PubMed    


  375. GILANI S, Jneid H
    Reaching the optimal volume-quality balance in transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:1186-1187.
    PubMed    


  376. ENG MH, Fang HK
    Forgotten and unforgiving.
    Catheter Cardiovasc Interv. 2022;99:1287-1288.
    PubMed    


  377. SIMPSON TF, Kheiri B, Chadderdon S, Song HK, et al
    TAVR operator volumes, trends, and geographic variations amongst Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2022;99:1181-1185.
    PubMed     Abstract available


  378. FABRY N, Hendrickson MJ, Arora S, Vavalle JP, et al
    Five-year trends in cause-specific readmissions and cost burden of mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1251-1256.
    PubMed     Abstract available


  379. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    PubMed     Abstract available


  380. RANARD LS, Vahl TP, Chung CJ, Sadri S, et al
    Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions.
    Catheter Cardiovasc Interv. 2022;99:1268-1276.
    PubMed     Abstract available


  381. BATLIVALA SP, Hagel JA, Hirsch R, Shahanavaz S, et al
    Transcatheter pulmonary valve-in-valve implantation within the expandable Inspiris Resilia(R) bioprosthetic valve.
    Catheter Cardiovasc Interv. 2022;99:1157-1160.
    PubMed     Abstract available


  382. KANG SL, Ramroop R, Manojlovich L, Runeckles K, et al
    Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation?
    Catheter Cardiovasc Interv. 2022;99:1138-1148.
    PubMed     Abstract available


  383. ABUSHOUK AI, Saad AM, Isogai T, Shekhar S, et al
    Long-term outcomes of transcatheter valve-in-valve replacement for failed aortic bioprosthesis: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1370-1372.
    PubMed    


  384. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    PubMed    


    February 2022
  385. ASAMI M, Dobner S, Stortecky S, Heg D, et al
    Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Feb 16. doi: 10.1002/ccd.30132.
    PubMed     Abstract available


  386. ELBADAWI A, Tan BE, Sammour Y, Saad M, et al
    Sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement: Insights from the National Readmissions Database.
    Catheter Cardiovasc Interv. 2022 Feb 7. doi: 10.1002/ccd.30072.
    PubMed     Abstract available


  387. VALVO R, Costa G, Tamburino C, Barbanti M, et al
    Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30116.
    PubMed     Abstract available


  388. BRUNNER S, Wolfrum M, Moccetti F, Stampfli SF, et al
    The relevance of tricuspid regurgitation in patients undergoing percutaneous treatment of mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30114.
    PubMed     Abstract available


  389. KITE TA, Ladwiniec A, Owens CG, Chase A, et al
    Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
    Catheter Cardiovasc Interv. 2022;99:305-313.
    PubMed     Abstract available


  390. KHAN AA, Dangas G
    Is cardiac surgery backup required for left main stenting?
    Catheter Cardiovasc Interv. 2022;99:607-608.
    PubMed    


  391. POSTALIAN A, Krajcer Z
    Facilitating future access to the coronary arteries in patients who need transcatheter aortic valve replacement: A significant step in the right direction.
    Catheter Cardiovasc Interv. 2022;99:932-933.
    PubMed    


  392. GOLDSWEIG AM, Baron SJ
    Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:904-905.
    PubMed     Abstract available


  393. UPADHYAY A, Jneid H
    Predischarge transthoracic echocardiogram after TAVI - Is it really necessary?
    Catheter Cardiovasc Interv. 2022;99:867-868.
    PubMed    


  394. O'NEILL BP, Wang DD, Caranasos TG, Chitwood WR Jr, et al
    Initial in-human experience with the conveyor cardiovascular system for the delivery of large profile transcatheter valve devices.
    Catheter Cardiovasc Interv. 2022;99:943-948.
    PubMed     Abstract available


  395. WELLE GA, El-Sabawi B, Thaden JJ, Greason KL, et al
    Effect of eliminating pre-discharge transthoracic echocardiogram on outcomes after TAVR.
    Catheter Cardiovasc Interv. 2022;99:861-866.
    PubMed     Abstract available


  396. MCINERNEY A, Travieso Gonzalez A, Castro Mejia A, Tirado-Conte G, et al
    Long-term outcomes after deferral of revascularization of in-stent restenosis using fractional flow reserve.
    Catheter Cardiovasc Interv. 2022;99:723-729.
    PubMed     Abstract available


  397. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    PubMed     Abstract available


    January 2022
  398. ZHOU D, Chen J, Fan J, Yidilisi A, et al
    Self-expanding transcatheter aortic valve replacement in patients with extremely horizontal aortas.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30094.
    PubMed     Abstract available


  399. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    PubMed     Abstract available


  400. OGAMI T, Kurlansky P, Takayama H, Ning Y, et al
    Three-year survival of transcatheter versus surgical aortic valve replacement in dialysis.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30045.
    PubMed     Abstract available


  401. PAULUS MG, Meindl C, Hamerle M, Schach C, et al
    Reduction of radiation exposure during transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30046.
    PubMed     Abstract available


  402. CHEN S, Li J, Qiu M, Ma S, et al
    Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
    PubMed     Abstract available


  403. LI J, Liu X, Ma S, Na K, et al
    Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
    PubMed     Abstract available


  404. YUAN S, He J, Cai Z, Zhang R, et al
    Intra-aortic balloon pump in cardiogenic shock: A propensity score matching analysis.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30102.
    PubMed     Abstract available


  405. HONG XL, Li Y, Fu GS, Zhang WB, et al
    Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
    PubMed     Abstract available


  406. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    PubMed     Abstract available


  407. LAWLOR MK, Hamid N, Kampaktsis P, Ning Y, et al
    Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30073.
    PubMed     Abstract available


  408. KATO N, Pellikka PA, Scott CG, Lee AT, et al
    Impact of mitral intervention on outcomes of patients with mitral valve dysfunction and annulus calcification.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30093.
    PubMed     Abstract available


  409. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    PubMed     Abstract available


  410. SCHOECHLIN S, Hein M, Brennemann T, Eichenlaub M, et al
    5-Year outcomes after transcatheter aortic valve implantation: Focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30083.
    PubMed     Abstract available


  411. FREIXA X, Estevez-Loureiro R, Pascual I, Carrasco-Chinchilla F, et al
    Procedural and clinical outcomes after repeat edge-to-edge transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30053.
    PubMed     Abstract available


  412. PARAGGIO L, Burzotta F, Graziani F, Aurigemma C, et al
    Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30082.
    PubMed     Abstract available


  413. LI Y, Li J, Qiu M, Ma S, et al
    Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
    PubMed     Abstract available


  414. ADAMO M, Pagnesi M, Popolo Rubbio A, Branca L, et al
    Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30062.
    PubMed     Abstract available


  415. CHIOU A, Yap J, Russo S, Stripe BR, et al
    Understanding repeat hospitalizations in intermediate-to-high risk aortic stenosis patients following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30066.
    PubMed     Abstract available


  416. CAJIGAS HR, Kaptzan T, Lewis B, El-Sabbagh A, et al
    The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30057.
    PubMed     Abstract available


  417. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    PubMed     Abstract available


  418. SIMARD T, Lloyd J, Crestanello J, Thaden JJ, et al
    Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30059.
    PubMed     Abstract available


  419. SIMSEK B, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention in prior coronary artery bypass graft surgery patients: Caveat Emptor!
    Catheter Cardiovasc Interv. 2022;99:85-87.
    PubMed    


  420. OKUYA Y, Moussa ID
    Surgical bailout after transcatheter aortic valve replacement: Hospital procedural volume matters!
    Catheter Cardiovasc Interv. 2022;99:169-170.
    PubMed    


  421. BELARDI J, Lamelas P
    Serious adverse events related to transcatheter aortic valve replacement are infrequent: FORWARD 3-years.
    Catheter Cardiovasc Interv. 2022;99:179-180.
    PubMed    


  422. UPADHYAY A, Jneid H
    Frailty and malnutrition as influential drivers of outcomes after aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:158-159.
    PubMed    


  423. RODRIGUEZ OGANDO A, Ballesteros F, Martinez JLZ
    Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;99:E38-E42.
    PubMed     Abstract available


  424. MOVAHED MR
    Distal administration of very high doses of adenosine using over-the-wire balloon or export catheter should be the first choice for treatment of patients with resistant no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E43.
    PubMed    


    December 2021
  425. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    PubMed     Abstract available


  426. VOGL BJ, Darestani YM, Lilly SM, Thourani VH, et al
    Impact of blood pressure on coronary perfusion and valvular hemodynamics after aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 22. doi: 10.1002/ccd.30052.
    PubMed     Abstract available


  427. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    PubMed     Abstract available


  428. OKOH AK, Chen C, Kassotis J, Soliman F, et al
    Utilizing ambulatory electrocardiogram monitoring to reduce conduction related death after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 1. doi: 10.1002/ccd.30027.
    PubMed     Abstract available


  429. KORNOWSKI R
    Left main coronary revascularization strategies in the COVID-19 era.
    Catheter Cardiovasc Interv. 2021;98:1262-1263.
    PubMed    


  430. KUMAR A, Jneid H
    Predicting mortality after percutaneous coronary intervention: The need for improved risk models.
    Catheter Cardiovasc Interv. 2021;98:1298-1299.
    PubMed    


  431. MOUSSA ID
    Prediction of left circumflex artery impingement after indirect mitral annuloplasty with the carillon device: "There is more to this than meets the eye!"
    Catheter Cardiovasc Interv. 2021;98:1402-1403.
    PubMed    


  432. SAIA F
    Transcatheter edge-to-edge mitral valve repair: Should we stay tied to COAPT tiers?
    Catheter Cardiovasc Interv. 2021;98:1413-1414.
    PubMed    


  433. TOPAZ O
    Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
    Catheter Cardiovasc Interv. 2021;98:1250-1251.
    PubMed    


  434. SCHNEIDER LM, Nicoleta N, Schepperle N, Paukovitsch M, et al
    Implications of concomitant obstructive or restrictive pulmonary diseases on functional and clinical results after MitraClip.
    Catheter Cardiovasc Interv. 2021;98:E1000-E1006.
    PubMed     Abstract available


  435. OJEDA S, Azzalini L, Suarez de Lezo J, Johal GS, et al
    Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1241-1249.
    PubMed     Abstract available


    November 2021
  436. BHARDWAJ B, Gunzburger E, Valle JA, Grunwald GK, et al
    Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.
    Catheter Cardiovasc Interv. 2021 Nov 30. doi: 10.1002/ccd.30024.
    PubMed     Abstract available


  437. WANG DD, O'Neill BP, Caranasos TG, Chitwood WR Jr, et al
    Comparative differences of mitral valve-in-valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves.
    Catheter Cardiovasc Interv. 2021 Nov 29. doi: 10.1002/ccd.30011.
    PubMed     Abstract available


  438. HOKKEN TW, de Ronde M, Wolff Q, Schermers T, et al
    Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program.
    Catheter Cardiovasc Interv. 2021 Nov 27. doi: 10.1002/ccd.30026.
    PubMed     Abstract available


  439. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    PubMed     Abstract available


  440. GUNARATHNE A, Tan J, Varcoe R, Bhandari S, et al
    The impact of learning-curve-experience on transcatheter aortic valve replacement outcomes: Insights from the United Kingdom and Ireland all-comers second-generation ACURATE neo transcatheter aortic heart valve registry.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30000.
    PubMed     Abstract available


  441. DAS TM, Shin J, Czarny MJ, Nanavati J, et al
    Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30009.
    PubMed     Abstract available


  442. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    PubMed     Abstract available


  443. NEUSER J, Kempf T, Bauersachs J, Widder JD, et al
    Novel self-expanding ALLEGRA transcatheter aortic valve for native aortic stenosis and degenerated bioprosthesis.
    Catheter Cardiovasc Interv. 2021 Nov 17. doi: 10.1002/ccd.30003.
    PubMed     Abstract available


  444. DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
    Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
    Catheter Cardiovasc Interv. 2021;98:1144-1151.
    PubMed    


  445. WOLFRUM M, Moccetti F, Piuhola J, Lehtola H, et al
    The Allegra transcatheter heart valve: Short term results from a multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1204-1209.
    PubMed     Abstract available


  446. ENG MH, Abbas AE, Hahn RT, Lee J, et al
    Real world outcomes using 20 mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29 mm)-a propensity matched analysis.
    Catheter Cardiovasc Interv. 2021;98:1185-1192.
    PubMed     Abstract available


  447. ORVIN K, Perl L, Landes U, Dvir D, et al
    Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry.
    Catheter Cardiovasc Interv. 2021;98:E862-E869.
    PubMed     Abstract available


  448. DE MARCO F, Casenghi M, Spagnolo P, Popolo Rubbio A, et al
    A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique.
    Catheter Cardiovasc Interv. 2021;98:E847-E854.
    PubMed     Abstract available


  449. RAZUK V, Camaj A, Cao D, Nicolas J, et al
    Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2021;98:E870-E880.
    PubMed     Abstract available


  450. NAZIR S, Ahuja KR, Ariss RW, Hassanein M, et al
    Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure.
    Catheter Cardiovasc Interv. 2021;98:E839-E846.
    PubMed     Abstract available


  451. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Karacsonyi J, et al
    Radial versus femoral access in patients with coronary artery bypass surgery: Frequentist and Bayesian meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 14. doi: 10.1002/ccd.30010.
    PubMed     Abstract available


  452. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    PubMed    


  453. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    PubMed     Abstract available


  454. REILLY JP, Parikh PB
    Valve-in-valve transcatheter aortic valve replacement versus re-do surgical aortic valve replacement: A call for randomized controlled trials.
    Catheter Cardiovasc Interv. 2021;98:948-949.
    PubMed    


  455. ARSLAN F, Gerckens U
    Virtual support for remote proctoring in TAVR during COVID-19.
    Catheter Cardiovasc Interv. 2021;98:E733-E736.
    PubMed     Abstract available


  456. BAGUR R, Jneid H
    Coronary artery access after aortic valve intervention.
    Catheter Cardiovasc Interv. 2021;98:957-958.
    PubMed    


  457. KIM JY, Kim SH, Jang SI
    Bilateral branch pulmonary artery Pulsta valve implantation for treatment of large right ventricular outflow tract in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;98:923-927.
    PubMed     Abstract available


  458. LE RUZ R, Plessis J, Houeijeh A, Baruteau AE, et al
    Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5-year follow-up in a French Registry.
    Catheter Cardiovasc Interv. 2021;98:990-999.
    PubMed     Abstract available


  459. LEE SY, Kim GB, Kim SH, Jang SI, et al
    Mid-term outcomes of the Pulsta transcatheter pulmonary valve for the native right ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021;98:E724-E732.
    PubMed     Abstract available


  460. KAPLE RK, Agarwal V, Azarbal A, Sugeng L, et al
    Tricuspid clip implantation using the MitraClip system-A step-by-step guide.
    Catheter Cardiovasc Interv. 2021;98:1006-1019.
    PubMed     Abstract available


  461. KHAN AA, Murtaza G, Khalid MF, White CJ, et al
    Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:884-892.
    PubMed     Abstract available


  462. WIEBE J, Rai H, Kuna C, Cassese S, et al
    Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Catheter Cardiovasc Interv. 2021;98:857-862.
    PubMed     Abstract available


    October 2021
  463. AMIN R, Arunothayaraj S, Kirtchuk D, Williams T, et al
    Mobility aids predict mortality after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Oct 22. doi: 10.1002/ccd.29981.
    PubMed     Abstract available


  464. SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
    Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
    Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
    PubMed     Abstract available


  465. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    PubMed     Abstract available


  466. STANOVA V, Rieu R, Cote N, Salaun E, et al
    In vitro Doppler versus catheter transvalvular pressure gradients in balloon-expandable versus self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2021 Oct 11. doi: 10.1002/ccd.29974.
    PubMed     Abstract available


  467. TANG GHL, Sengupta A, Alexis SL, Zaid S, et al
    Conventional versus modified delivery system technique in commissural alignment from the Evolut low-risk CT substudy.
    Catheter Cardiovasc Interv. 2021 Oct 9. doi: 10.1002/ccd.29973.
    PubMed     Abstract available


  468. MATSUMOTO S, Ohno Y, Miyamoto J, Ikari Y, et al
    Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2021 Oct 6. doi: 10.1002/ccd.29960.
    PubMed     Abstract available


  469. MUSUMECI G, Annibali G
    Transcarotid access as a first alternative approach to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021;98:774-775.
    PubMed    


  470. OKUYA Y, Moussa ID
    Hemolysis after transcatheter mitral valve replacement: An underreported phenomenon!
    Catheter Cardiovasc Interv. 2021;98:786-787.
    PubMed    


  471. HAWAMDEH H, Moliterno DJ
    Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;98:689-690.
    PubMed     Abstract available


  472. KERN MJ
    Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
    Catheter Cardiovasc Interv. 2021;98:669-670.
    PubMed    


  473. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    PubMed     Abstract available


  474. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    PubMed     Abstract available


  475. BRINKMANN C, Abdel-Wahab M, Bedogni F, Bhadra OD, et al
    Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study.
    Catheter Cardiovasc Interv. 2021;98:756-764.
    PubMed     Abstract available


  476. GARCIA-SAYAN E, Raghunathan D, Li FM, Dhoble A, et al
    Initial experience with the fourth generation MitraClip: Outcomes, procedural aspects, and considerations for device selection.
    Catheter Cardiovasc Interv. 2021;98:E626-E636.
    PubMed     Abstract available


  477. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    PubMed     Abstract available


    September 2021
  478. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    PubMed     Abstract available


  479. ELBADAWI A, Mahta D, Elgendy IY, Dang AT, et al
    Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2021 Sep 27. doi: 10.1002/ccd.29963.
    PubMed     Abstract available


  480. LEE DU, Han J, Fan GH, Hastie DJ, et al
    The clinical impact of chronic liver disease in patients undergoing transcatheter and surgical aortic valve replacement: Systematic analysis of the 2011-2017 US hospital database.
    Catheter Cardiovasc Interv. 2021 Sep 25. doi: 10.1002/ccd.29952.
    PubMed     Abstract available


  481. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    PubMed    


  482. ALKHOULI M, Jneid H
    Optimal management of acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2021;98:613-614.
    PubMed    


  483. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    PubMed     Abstract available


  484. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    PubMed     Abstract available


  485. PETRI N, Lengenfelder B, Voelker W, Nordbeck P, et al
    Interventional closure of aortomitral perforation after TAVR: A case report.
    Catheter Cardiovasc Interv. 2021;98:E483-E485.
    PubMed     Abstract available


  486. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    PubMed     Abstract available


  487. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    PubMed     Abstract available


  488. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    PubMed     Abstract available


    August 2021
  489. BRUGGER N, Kassar M, Siontis GCM, Widmer S, et al
    Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2021 Aug 18. doi: 10.1002/ccd.29916.
    PubMed     Abstract available


  490. GARCIA-GOMEZ M, Delgado-Arana JR, Halim J, De Marco F, et al
    Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29923.
    PubMed     Abstract available


  491. MINHA S, Yarkoni Y, Segev A, Finkelstein A, et al
    Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation-A retrospective cohort study.
    Catheter Cardiovasc Interv. 2021 Aug 4. doi: 10.1002/ccd.29891.
    PubMed     Abstract available


  492. GUDDETI RR, Pajjuru VS, Walters RW, Garcia SA, et al
    Impact of gender on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter edge-to-edge mitral valve repair: Analysis from the National Readmission Database.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29887.
    PubMed     Abstract available


  493. BELARDI JA, Lamelas PM
    New TAVR item added to cart for large scale clinical testing.
    Catheter Cardiovasc Interv. 2021;98:380-381.
    PubMed    


  494. POSTALIAN A, Krajcer Z
    Individualizing risk assessment for conduction system injury after alcohol septal ablation.
    Catheter Cardiovasc Interv. 2021;98:401-402.
    PubMed    


  495. FRANZONE A, Esposito G
    Transcatheter aortic valve thrombosis: The more we see the more we know.
    Catheter Cardiovasc Interv. 2021;98:363-364.
    PubMed    


  496. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    PubMed     Abstract available


  497. GRINES CL, Klein AJ, Bauser-Heaton H, Alkhouli M, et al
    Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease.
    Catheter Cardiovasc Interv. 2021;98:277-294.
    PubMed     Abstract available


  498. RIMMAUDO F, Angelini G, Condello I
    Thrombocytopenia after TAVI in patients with low body mass index.
    Catheter Cardiovasc Interv. 2021;98:E329-E331.
    PubMed    


  499. KREUTZER J, Armstrong AK, Rome JJ, Zellers TM, et al
    Comparison of the investigational device exemption and post-approval trials of the Melody transcatheter pulmonary valve.
    Catheter Cardiovasc Interv. 2021;98:E262-E274.
    PubMed     Abstract available


  500. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    PubMed     Abstract available


  501. QURESHI WT, Parker M, Walker J, Kakouros N, et al
    Equipment entrapment during redo-TAVR with successful BASILICA procedure.
    Catheter Cardiovasc Interv. 2021;98:E320-E323.
    PubMed     Abstract available


  502. HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
    Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
    Catheter Cardiovasc Interv. 2021;98:411-412.
    PubMed    


  503. JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
    What have we learnt from the use of papyrus covered stent in France and Spain?
    Catheter Cardiovasc Interv. 2021;98:410.
    PubMed    


  504. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    PubMed     Abstract available


    July 2021
  505. STAUDACHER DL, Braxmeier K, Stachon P, Hilgendorf I, et al
    Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29885.
    PubMed     Abstract available


  506. VAN MIEGHEM NM, Windecker S, Manoharan G, Bosmans J, et al
    Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29889.
    PubMed     Abstract available


  507. URENA M, Lemann T, Chong-Nguyen C, Brochet E, et al
    Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification.
    Catheter Cardiovasc Interv. 2021 Jul 15. doi: 10.1002/ccd.29874.
    PubMed     Abstract available


  508. OGUZ D, Padang R, Pislaru SV, Nkomo VT, et al
    Clinical predictors and impact of postoperative mean gradient on outcome after transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2021 Jul 10. doi: 10.1002/ccd.29867.
    PubMed     Abstract available


  509. CILINGIROGLU M, Okutucu S
    TAVR in patients with end stage liver and renal disease: Lifesaving and increasing transplant eligibility.
    Catheter Cardiovasc Interv. 2021;98:168-169.
    PubMed    


  510. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    PubMed     Abstract available


  511. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    PubMed     Abstract available


  512. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    PubMed     Abstract available


  513. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    PubMed     Abstract available


  514. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    PubMed     Abstract available


    June 2021
  515. ROTTLANDER D, Godde M, Degen H, Ogutcu A, et al
    Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography.
    Catheter Cardiovasc Interv. 2021 Jun 25. doi: 10.1002/ccd.29824.
    PubMed     Abstract available


  516. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Prognostic impact of echocardiographic mean transvalvular gradients in patients with aortic stenosis and low flow undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jun 17. doi: 10.1002/ccd.29840.
    PubMed     Abstract available


  517. NICOLAS J, Guedeney P, Claessen BE, Mehilli J, et al
    Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.
    Catheter Cardiovasc Interv. 2021 Jun 12. doi: 10.1002/ccd.29807.
    PubMed     Abstract available


  518. SALEEM S, Ullah W, Syed MA, Megaly M, et al
    Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2021 Jun 10. doi: 10.1002/ccd.29789.
    PubMed     Abstract available


  519. GRINES CL, Leach C
    Acute myocardial infarction related cardiogenic shock: How important is vascular access site?
    Catheter Cardiovasc Interv. 2021;97:1367-1368.
    PubMed    


  520. COSTELLO BT, Krajcer Z
    Editorial Comments for: "Transcatheter valve-in-valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis".
    Catheter Cardiovasc Interv. 2021;97:1479-1480.
    PubMed    


  521. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    PubMed     Abstract available


  522. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    PubMed     Abstract available


  523. IMAMURA T, Narang N
    Improving clinical outcomes following MitraClip.
    Catheter Cardiovasc Interv. 2021;97:E1053.
    PubMed    


    May 2021
  524. LIM DS, Smith RL, Zahr F, Dhoble A, et al
    Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2021 May 18. doi: 10.1002/ccd.29749.
    PubMed     Abstract available


  525. LIU X, Pu Z, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly Transcatheter Repair device-First in man implantation in China.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29687.
    PubMed     Abstract available


  526. TARANTINI G, Fraccaro C
    Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:1268-1269.
    PubMed    


  527. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    PubMed     Abstract available


  528. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    PubMed     Abstract available


  529. BELHAJ SOULAMI R, Castro M, Haigron P, Verhoye JP, et al
    Computer-assisted valve in valve in a deteriorated Mosaic valve using a library of bioprostheses.
    Catheter Cardiovasc Interv. 2021;97:E893-E896.
    PubMed     Abstract available


  530. SAAD AM, Kassis N, Gad MM, Abdelfattah O, et al
    Impact of atrial fibrillation on outcomes following MitraClip: A contemporary population-based analysis.
    Catheter Cardiovasc Interv. 2021;97:1252-1256.
    PubMed     Abstract available


  531. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    PubMed     Abstract available


  532. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    PubMed     Abstract available


  533. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    PubMed     Abstract available


    April 2021
  534. MORENO R, Baz JA, Moreu J, Berenguer A, et al
    Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra-annular device. The Spanish Allegra valve-in-valve (SAVIV) registry.
    Catheter Cardiovasc Interv. 2021 Apr 23. doi: 10.1002/ccd.29742.
    PubMed     Abstract available


  535. CHANDRA P, Jose J, Mattummal S, Mahajan AU, et al
    Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial.
    Catheter Cardiovasc Interv. 2021 Apr 20. doi: 10.1002/ccd.29733.
    PubMed     Abstract available


  536. MARTINEZ-GOMEZ E, McInerney A, Tirado-Conte G, de Agustin JA, et al
    Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29703.
    PubMed     Abstract available


  537. OKUNO T, Heg D, Lanz J, Praz F, et al
    Heart valve sizing and clinical outcomes in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29700.
    PubMed     Abstract available


  538. PANCHAL HB, Stone GW, Saxena A, Bursac Z, et al
    In-hospital outcomes after transcatheter edge-to-edge mitral valve repair in patients with chronic kidney disease: An analysis from the 2010-2016 National inpatient sample.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29712.
    PubMed     Abstract available


  539. COSTA G, D'Errigo P, Rosato S, Valvo R, et al
    Long-term outcomes of self-expanding versus balloon-expandable transcatheter aortic valves: Insights from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2021 Apr 13. doi: 10.1002/ccd.29701.
    PubMed     Abstract available


  540. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    PubMed     Abstract available


  541. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    PubMed     Abstract available


  542. IRIART X, Guerin P, Jalal Z, Thambo JB, et al
    Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29681.
    PubMed     Abstract available


    March 2021
  543. BOEDER NF, Bayer M, Dorr O, Nef HM, et al
    Fusion imaging guided implantation of a Tricento transcatheter heart valve for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 23. doi: 10.1002/ccd.29587.
    PubMed     Abstract available


  544. KABAHIZI A, Sheikh AS, Williams T, Tanseco K, et al
    Elective versus urgent in-hospital transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Mar 13. doi: 10.1002/ccd.29638.
    PubMed     Abstract available


  545. KITAMURA M, Fam NP, Braun D, Ruf T, et al
    12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29583.
    PubMed     Abstract available


    February 2021
  546. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    PubMed     Abstract available


  547. ESTEVEZ-LOUREIRO R, Shuvy M, Taramasso M, Benito-Gonzalez T, et al
    Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry).
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29552.
    PubMed     Abstract available


  548. HALE SM, Jessen M, Banerjee S, Kumbhani DJ, et al
    Successful transcatheter treatment for very late migration of a transcatheter aortic valve into the left ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29547.
    PubMed     Abstract available


  549. SA MPBO, Simonato M, Van den Eynde J, Cavalcanti LRP, et al
    Balloon versus self-expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29538.
    PubMed     Abstract available


  550. SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
    Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
    PubMed     Abstract available


  551. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    In-hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study.
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29517.
    PubMed     Abstract available


    January 2021
  552. MYAT A, Mouy F, Buckner L, Cockburn J, et al
    Survival relative to pacemaker status after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29498.
    PubMed     Abstract available


  553. QINTAR M, Wang DD, O'Neill WW, O'Neill B, et al
    Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of "Eustachian ridge?"
    Catheter Cardiovasc Interv. 2021 Jan 25. doi: 10.1002/ccd.29461.
    PubMed     Abstract available


  554. MEIJERINK F, Koch KT, de Winter RJ, Robbers-Visser D, et al
    Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome.
    Catheter Cardiovasc Interv. 2021 Jan 18. doi: 10.1002/ccd.29464.
    PubMed     Abstract available


  555. NIJENHUIS VJ, Meyer A, Brouwer J, Mahmoodi BK, et al
    The effect of transcatheter aortic valve implantation approaches on mortality.
    Catheter Cardiovasc Interv. 2021 Jan 14. doi: 10.1002/ccd.29456.
    PubMed     Abstract available


    December 2020
  556. TANSECO KV, Alsanjari O, Cockburn J, Hildick-Smith D, et al
    Amplatzer device closure of femoral pseudoaneurysm after transcatheter aortic valve implantation: An alternative to surgical repair.
    Catheter Cardiovasc Interv. 2020 Dec 22. doi: 10.1002/ccd.29424.
    PubMed     Abstract available


  557. ANCONA MB, Beneduce A, Romano V, Buzzatti N, et al
    Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29432.
    PubMed     Abstract available


  558. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    PubMed     Abstract available


  559. AMAT-SANTOS IJ, Santos-Martinez S, Conradi L, Taramasso M, et al
    Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29423.
    PubMed     Abstract available


    November 2020
  560. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    PubMed     Abstract available


  561. BAEKKE PS, Jorgensen TH, Sondergaard L
    Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29403.
    PubMed     Abstract available


  562. SUGIURA A, Weber M, Tabata N, Goto T, et al
    Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Nov 19. doi: 10.1002/ccd.29390.
    PubMed     Abstract available


  563. BENETOS G, Karmpalioti M, Drakopoulou M, Stathogiannis K, et al
    One-year clinical and echocardiographic outcomes of direct implantation of a self-expanding valve.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29389.
    PubMed     Abstract available


  564. ALARFAJ M, Jain T, Krepp J
    Transcatheter mitral valve thrombosis: A case report and literature review.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29374.
    PubMed     Abstract available


  565. SAYAH N, Simon F, Garceau P, Ducharme A, et al
    Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29365.
    PubMed     Abstract available


  566. CASENGHI M, Gorla R, Popolo Rubbio A, De Marco F, et al
    One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system.
    Catheter Cardiovasc Interv. 2020 Nov 6. doi: 10.1002/ccd.29353.
    PubMed     Abstract available


    October 2020
  567. ABU KHADIJA H, Ayyad O, Haberman D, Gandelman G, et al
    Contemporary transcatheter aortic valve implantation related thrombocytopenia.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29325.
    PubMed     Abstract available


  568. KORBER MI, Friedrichs KP, Aydin F, Pfister R, et al
    Impact of cleft-like indentations on procedural outcome of percutaneous edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29286.
    PubMed     Abstract available


    September 2020
  569. HOSHI T, Hiraya D, Sato A, Ieda M, et al
    Potential risk of perioperative thromboembolism in patients with antiphospholipid syndrome who undergo transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2020 Sep 25. doi: 10.1002/ccd.29300.
    PubMed     Abstract available


  570. MORITA Y, Endo A, Tanabe K
    Papillary muscle rupture after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29252.
    PubMed     Abstract available


  571. HASE H, Yoshijima N, Yanagisawa R, Tanaka M, et al
    Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29259.
    PubMed     Abstract available


  572. IMAMURA T
    How to prevent thrombosis following transcatheter aortic valve replacement during durable left ventricular assist device supports.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29268.
    PubMed    


  573. SHARMA SP, Chaudhary R, Ghuneim A, Harder W, et al
    Carotid access for transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29244.
    PubMed     Abstract available


    August 2020
  574. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States.
    Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29189.
    PubMed     Abstract available


  575. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    PubMed     Abstract available


  576. KASSIS N, Saad AM, Ahuja KR, Gad MM, et al
    Impact of thoracic aortic aneurysm on outcomes of transcatheter aortic valve replacement: A nationwide cohort analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29195.
    PubMed     Abstract available


  577. BIANCARI F, Pykari J, Savontaus M, Laine M, et al
    Early and late pace-maker implantation after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29177.
    PubMed     Abstract available


    July 2020
  578. YAMAMOTO M, Otsuka T, Shimura T, Yamaguchi R, et al
    Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 30. doi: 10.1002/ccd.29130.
    PubMed     Abstract available


  579. RAHEJA H, Ahuja KR, Nazir S, Saad AM, et al
    Association of baseline kidney disease with outcomes of transcatheter mitral valve repair by MitraClip.
    Catheter Cardiovasc Interv. 2020 Jul 23. doi: 10.1002/ccd.29129.
    PubMed     Abstract available


  580. SHEIKH MA, Deo SV, Riaz H, Raza S, et al
    Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 18. doi: 10.1002/ccd.29123.
    PubMed     Abstract available


  581. SATHANANTHAN J, Lauck S, Polderman J, Yu M, et al
    Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29124.
    PubMed     Abstract available


  582. CHIEW KLX, Lim PO
    Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
    PubMed     Abstract available


  583. COSTA G, Ihlemann N, Sondergaard L, De Backer O, et al
    Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29108.
    PubMed     Abstract available


  584. COSTA G, Bieliauskas G, Fukutomi M, Ihlemann N, et al
    Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program.
    Catheter Cardiovasc Interv. 2020 Jul 1. doi: 10.1002/ccd.29117.
    PubMed     Abstract available


    June 2020
  585. ROMEO FJ, Seropian IM, Chiabrando JG, Raleigh JV, et al
    Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 28. doi: 10.1002/ccd.29067.
    PubMed     Abstract available


  586. YOUNG L, Kapadia S, Khatri J
    Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
    Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
    PubMed    


  587. MATSUDA Y, Nai Fovino L, Giacoppo D, Scotti A, et al
    Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29105.
    PubMed     Abstract available


  588. SATHANANTHAN J, Green P, Finn M, Wood DA, et al
    Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.28981.
    PubMed     Abstract available


  589. TANG L, Sorajja P, Mooney M, Garberich R, et al
    Transcatheter aortic valve replacement in patients with severe comorbidities: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jun 8. doi: 10.1002/ccd.29063.
    PubMed     Abstract available


  590. MURPHY AC, Koshy AN, Cameron W, Horrigan M, et al
    Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.
    Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.28969.
    PubMed     Abstract available


    May 2020
  591. SIQUEIRA DA, Simonato M, Ramos AA, Bignoto T, et al
    Mid- to long-term clinical and echocardiographic outcomes after transcatheter aortic valve replacement with a new-generation, self-expandable system.
    Catheter Cardiovasc Interv. 2020 May 23. doi: 10.1002/ccd.28999.
    PubMed     Abstract available


  592. LI SX, Patel NK, Flannery LD, Cigarroa RJ, et al
    Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28989.
    PubMed     Abstract available


  593. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    PubMed     Abstract available


    April 2020
  594. SUN Y, Li J, Li G, Fan R, et al
    Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
    PubMed     Abstract available


  595. BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
    Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
    PubMed     Abstract available


    February 2020
  596. DALL'ARA G, Tumscitz C, Grotti S, Santarelli A, et al
    Contemporary balloon aortic valvuloplasty: Changing indications and refined technique.
    Catheter Cardiovasc Interv. 2020 Feb 25. doi: 10.1002/ccd.28807.
    PubMed     Abstract available


    January 2020
  597. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    PubMed     Abstract available


    December 2019
  598. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    PubMed     Abstract available


    November 2019
  599. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.